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Abstract
Machine Learning (ML) methods including Deep Learning (DL) Methods have been
employed in the medical field to improve diagnosis process and patient’s prognosis outcomes.
Glioblastoma multiforme is an extremely aggressive Glioma brain tumor that has a poor survival
rate. Understanding the behavior of the Glioblastoma brain tumor is still uncertain and some
factors are still unrecognized. In fact, the tumor behavior is important to decide a proper treatment
plan and to improve a patient’s health. The aim of this dissertation is to develop a ComputerAided-Diagnosis system (CADiag) based on ML/DL methods to automatically estimate the
Overall Survival Time (OST) for patients with Glioblastoma brain tumors from medical imaging
and non-imaging data. This system is developed to enhance and speed-up the diagnosis process,
as well as to increase understanding of the behavior of Glioblastoma brain tumors.
The proposed OST prediction system is developed based on a classification process to
categorize a GBM patient into one of the following three survival time groups: short-term (<10
months), mid-term (10-15 months), and long-term (>15 months). The Brain Tumor Segmentation
challenge (BraTS) dataset is used to develop the automatic OST prediction system. This dataset
consists of multimodal preoperative Magnetic Resonance Imaging (mpMRI) data, and clinical
data. The training data is relatively small in size to train an accurate OST prediction model based
on DL method. Therefore, traditional ML methods such as Support Vector Machine (SVM),
Neural Network, K-Nearest Neighbor (KNN), Decision Tree (DT) were used to develop the OST
prediction model for GBM patients. The main contributions in the perspective of ML field include:
developing and evaluating five novel radiomic feature extraction methods to produce an automatic
and reliable OST prediction system based on classification task. These methods are volumetric,
iii

shape, location, texture, histogram-based, and DL features. Some of these radiomic features can
be extracted directly from MRI images, such as statistical texture features and histogram-based
features. However, preprocessing methods are required to extract automatically other radiomic
features from MRI images such as the volume, shape, and location information of the GBM brain
tumors. Therefore, a three-dimension (3D) segmentation DL model based on modified U-Net
architecture is developed to identify and localize the three glioma brain tumor subregions,
peritumoral edematous/invaded tissue (ED), GD-enhancing tumor (ET), and the necrotic tumor
core (NCR), in multi MRI scans. The segmentation results are used to calculate the volume,
location and shape information of a GBM tumor. Two novel approaches based on volumetric,
shape, and location information, are proposed and evaluated in this dissertation. To improve the
performance of the OST prediction system, information fusion strategies based on data-fusion,
features-fusion and decision-fusion are involved. The best prediction model was developed based
on feature fusions and ensemble models using NN classifiers. The proposed OST prediction
system achieved competitive results in the BraTS 2020 with accuracy 55.2% and 55.1% on the
BraTS 2020 validation and test datasets, respectively.
In sum, developing automatic CADiag systems based on robust features and ML methods,
such as our developed OST prediction system, enhances the diagnosis process in terms of cost,
accuracy, and time. Our OST prediction system was evaluated from the perspective of the ML
field. In addition, preprocessing steps are essential to improve not only the quality of the features
but also boost the performance of the prediction system. To test the effectiveness of our developed
OST system in medical decisions, we suggest more evaluations from the perspective of biology
and medical decisions, to be then involved in the diagnosis process as a fast, inexpensive and
automatic diagnosis method. To improve the performance of our developed OST prediction
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system, we believe it is required to increase the size of the training data, involve multi-modal data,
and/or provide any uncertain or missing information to the data (such as patients' resection statuses,
gender, etc.). The DL structure is able to extract numerous meaningful low-level and high-level
radiomic features during the training process without any feature type nominations by researchers.
We thus believe that DL methods could achieve better predictions than ML methods if large size
and proper data is available.
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Chapter 1- Introduction

1.1 Background
A brain tumor is an abnormal growth of cells in the brain. There are two types of brain
tumors: malignant and benign. Malignant tumors are aggressive tumors that contain cancerous
cells and are life-threatening. Benign tumors are those tumors that do not contain cancerous cells,
and patients usually survive after proper treatment if the tumors are not located in a vital region of
a brain. Malignant tumors have high growth rates and irregular boundaries, while benign tumors
have low growth rates, and distinct boundaries. Certain risk factors increase a person’s chance of
developing brain tumors, and some factors cannot be controlled, such as age, family history, and
genetics. Other factors can be controlled and are related to a patient’s behavior, such as alcohol
intake, smoking, and dietary habits. Ionizing radiation is another factor that has a strong association
with the development of brain tumors, and unfortunately, it is found that prenatal diagnostic x-ray
exposure raises the risk of childhood brain tumors [1, 2]. However, the main cause of brain tumors
is still unknown and uncertain.
Gliomas are common brain tumors that start in glial cells, which are the supporting cells
of the brain and spinal cord, and infiltrating the surrounding tissues [3, 4]. These tumors are slightly
more common in men than in women [5-7]. There are two types of gliomas based on their growth
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rate: Low-Grade Glioma (LGG) which are classified as benign brain tumors, and High-Grade
Glioma (HGG), which are classified as malignant brain tumors [8]. The World Health
Organization (WHO) classifies the glioma tumors into four grades (I -IV) based on the level of
malignancy [5, 9, 10]. Grade I and grade II gliomas are identified as LGG tumors, and grade III
and grade IV are identified as HGG tumors [9-11]. Pilocytic astrocytoma is a grade I glioma, and
diffuse astrocytoma is a grade II glioma [10]. All the grade I and most of the grade II gliomas are
benign. However, Magnetic Resonance Imaging (MRI) and computerized tomography (CT) scan
are required for patients with grade II glioma to observe any tumor recurrence or change to HGG
[3]. An anaplastic astrocytoma and Glioblastoma multiforme (GBM) are known as grade III and
grade IV of gliomas, respectively [10,12,13]. GBM is an aggressive brain tumor with a low
survival rate after diagnosis [14, 15]. It represents about 50% of Gliomas [9, 13, 16], and 90% of
the GBMs are primary tumors [13, 17]. Unfortunately, 20% of GBM patients were diagnosed
previously with LGG [1]. According to the American Cancer Society (ACS), the survival rate is
related to a patient’s age and it is better for young people than old people [18, 19]; for example,
the 5-years relative survival rate is 22%, 9%, and 6% for patients with age (20-44) years, (45-54)
years, and (55-64) years, respectively [19]. Many factors relate to patients’ overall survival time
(OST) after a brain tumor diagnosis, such as patients’ age, functional level, volume and location
of the brain tumor, type of brain tumor, grade and level of brain tumor, genetic alterations, and
certain gene mutations or changes in tumor cells [13, 20-24]. However, there are factors that have
not been recognized and identified yet. In addition, patients’ lifestyle behaviors such as smoking,
alcohol intake, and dietary habits could be reasons to increase or decrease the patients’ survival
rate [25]. Different tests are required to diagnose glioma brain tumors such as neurological exams,
imaging tests, and biopsy tests [26-28]. To identify the size and location of glioma brain tumors,
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imaging tests like MRI and CT scans are required [27]. In general, an MRI is commonly used as
the best imaging test to identify the size and location of a brain tumor, such as glioma, due to its
perfect tissue contrast which provides more complex visualization and the heterogeneity of a brain
tumor [27, 29]. In general, a glioma brain tumor consists of three sub-regions: peritumoral
edematous/invaded tissue (ED), GD-enhancing tumor (ET), and the necrotic tumor core (NCR)
[30, 31]. Each of these sub-regions can be visible in a specific structural MRI modality, therefor,
different structural MRI modalities have been used to annotate the glioma brain tumor sub-regions.
For example, fluid-attenuated inversion recovery (FLAIR) is used to annotate the Whole Tumor
(WT) region, T2-weighted (T2) is used to annotate the Tumor Core (TC), and experts compared
T1-weighted (T1) with T1-weighted Gadolinium contrast (T1 Gd) to annotate both the Enhancing
Tumor structures (ET) and the surrounding cystic/necrotic components of the core (Non-Enhanced
tumor core (NE)) [30, 31].
Most research aspects on GBM tumors focus on improving the diagnosis process and
treatment plans, which are essential to improving patients’ health, as well as increasing their
survival rate.
Misdiagnosis and improper treatment plans are high-risk factors that affect patients’ lives [32-36].
Recently, machine learning (ML) and deep learning (DL) methods have been used as AI methods
to improve the diagnosis process and prognosis outcomes by processing medical data and
performing accurate automatic predictions [37- 42]. Although the DL method is a subset of ML
methods, most studies use the term ML to refer to all traditional ML methods, such as Support
Vector Machine (SVM), Neural Network (NN), K-Nearest Neighbor (KNN), Decision Tree (DT),
…etc., excluding DL methods. Therefore, we use the term ML in this dissertation to refer to all
traditional ML methods, and use the term DL for deep learning neural network methods only. ML
3

and DL are prediction methods to develop prediction models, and these models identify complex
patterns in data that have nonlinearity nature which cannot be defined by using statistical methods.
These prediction systems are important for providing better understanding of a disease behavior,
identifying early diagnosis signs, as well as deciding a proper treatment plan after diagnosis [37,
43]. Using a proper ML/DL algorithm for medical predictions depends on several factors, such as
data size, data type, hardware availability (size and type of memory and GPU card), and prediction
task type.
The availability of proper data is the core of developing efficient ML/DL prediction
models. In fact, it is still challenging to develop reliable prediction models in the medical field due
to difficulties in providing adequate data and identifying the proper prediction algorithms. When
the term of proper data for developing an efficient prediction model could mean data with enough
samples, data containing adequate meaningful attributes or information, data with perfect labels or
annotations, clean/clear data free of noise or redundant information, or/and balanced data that
contains a mostly equal number of samples in different classes/groups [44, 45]. Developing
accurate OST prediction systems are essential to understanding a diseases’ behavior which is
crucial for clinical decision [46-49]. Various medical data types are used to develop automatic
OST prediction models, such as genomics data [50-53], clinical data [54-56], radiology data [5767], or multimodal data which includes a combination of different types of medical
data. However, it is still challenging to find perfect multimodal medical data to predict OS for
tumors.
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1.2 Related Work
Diagnostic errors including missed, improper, or delayed diagnosis, are high risk factors
that affect peoples’ lives [34, 68]. In addition, diagnosing and treatment fatal diseases, such as
brain tumors, are costly and time consuming, which adds an additional burden to patient’s
suffering. Collaboration and integration of various disciplines are required to overcome/reduce
healthcare weaknesses. Therefore, machine ML and DL techniques have been widely used to
improve the medical field by enhancing the diagnosis process [69], drug discovery [69, 70], and
developing proper treatment plans [71-74].
In general, the type and size of a dataset is a good way to decide whether traditional ML
methods or DL methods, are proper for a prediction task. Recently, most studies focus on
developing DL models in the medical field due to their ability to achieve accurate predictions [7577]. Basically, DL is a deep structure of NN that contains many layers, and this deep structure
characterizes its ability to derive numerous meaningful high-level descriptors from data during the
training process to develop non-linear complex patterns [78, 79]. However, DL methods mostly
require a large size and well annotated data to train accurate prediction models [81]. In addition,
most DL models require large amount of memory and special Graphical Processing Units (GPUs)
to deal with complex computations and large input patches [79-82]. Traditional ML methods and
meaningful descriptors (i.e., features) aid to developing reliable prediction systems when only
small image data is available [58-62]. However, various efficient DL structures (i.e., models) have
been developed for segmentation tasks to deal with small medical imaging data that has large
sample (i.e. patch) sizes due to its 3D nature, such as nnU-Net [83], U-Net [84], Vnet [85],
VoxResNet [86], XmasNet [87], and autoencoder Regularization [88].
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Studying overall survival time is one research aspect in the medical field that attracts
interest to improve the understanding of disease behaviors. Better understanding the behavior of
fatal diseases is an important factor in deciding a proper treatment method to increase the survival
rate and improve prognosis outcomes [57, 89]. The importance of patients’ survival time has been
studied in two different research directions. The first direction is based on survival analysis [90,
91], and the second direction is based on overall survival time predictions [58-63]. Different
survival analysis methods are used to improve prognosis outcomes for patients with cancer, such
as Kaplan tests, logrank tests, and proportional cox models. These methods study the occurrence
of an event (i.e. death) in a specific group of patients [90, 91]. ML/DL methods offer the possibility
to derive automatic estimation systems from various datasets and discover latent relations between
data attributes to predict outcomes. Therefore, various studies use ML/DL methods to develop
efficient OST prediction models using various types of medical data. These prediction models are
designed to improve patient outcomes, enhance the assessment of prognosis and decision making,
and improve institutional performance in managing fatal diseases [53, 92, 93].
Various types of medical data were used to develop reliable OST prediction systems for
different cancers, such as radiology data [57, 58-64, 89, 94, 95], electronic administrative record
data (EAR) [93], histology [96, 97], and genomics data [50, 52, 96, 98]. Gupta et al. used the EAR
data to train a classification ML model to predict OST for patients with different types of cancers
[93]. Their system classifies patients with cancers into three survival classes: six months, twelve
months, and twenty-four months. The ERA data contains tumor information, as well as patient
information, such as gender, age, tumor characteristics, histological grade, tumor size, human
epidermal growth factor receptor 2 (HER2), etc. They found that ensemble SVM achieved better
performance than clinical panels in predicting OST. Radiology data includes different types of
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medical imaging data that are created by specific machines, such as Computerized Tomography
(CT) scan, Magnetic Resonance Imaging (MRI), and X-ray. This type of medical data are vital
tests to diagnose and treat serious diseases and injuries due to their ability to identify location, size,
and even types of abnormality and illness in a defective organ. Thus, extensive research studies
focus on using radiology data in developing prediction systems to improve diagnosis and prognosis
outcomes, such as OST predictions [57, 58-64, 89, 94, 95]. However, most of the available
survival radiology data are small in terms of the number of samples. Thus, radiomic extraction
methods have been developed to extract meaningful and robust descriptors from a radiology data.
Radiomics represent the high-level information that are evolved from radiology imaging data.
They are meaningful information in a quantitative form that are used to develop automatic
prediction models based on ML methods [99-101]. Various radiomic feature have been proposed
to develop OST prediction model, such as texture [59-61, 94, 102], statistical [59, 103], volumetric
[66, 80], shape [66, 94], morphological, [57, 59], and histogram-based features [59, 64] for head
and neck squamous cell carcinoma, pancreatic ductal adenocarcinoma, lung cancers, breast
cancers, and GBM brain tumors. In addition, researchers used DL based on transfer learning
techniques to extract radiomic features, called deep radiomic features, from medical images [58,
62, 89]. Table 1.1 lists OST predictions systems based on medical data for different types of
cancers. Sun et al. developed an OST prediction system based on preoperative CT images and ML
methods for non-small cell lung cancer (NSCLC) patients [57]. To produce an accurate prediction
model, different types of ML methods and radiomic features include intensity, fine texture, coarse
and morphological features. To reduce the dimensionality of feature vectors, various types of
feature selection methods were used. Nie et al. proposed extracting deep features from preoperative
multimodal MRI images, contrast-enhanced T1-weighted (T1ce), diffusion tensor imaging (DTI),
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and resting-state functional MRI (rs-fMRI), to predict OST for HGG patients [89]. The authors
extracted DL features from the tumor volume and combined them with tumor-related features
(tumor size and histology type) and patients’ age to produce a robust feature vector. Then they
used the robust features to train a binary SVM classifier. They concluded that this combination of
features developed a proper prognosis prediction model for HGG patients. In [59], Leger et al.
extracted statistical, morphological, histogram-based, and texture features from CT scans to
develop an automatic OST prediction system based on non-parametric regression, and fullparametric ML methods for head and neck squamous cell carcinoma. In another study [58],
Haarburger et al. used CT scans to extract radiomic features as well as DL features based on pretrained ResNet develop a classification hazard prediction model for lung cancer. Zhang et al.
extracted radiomics and deep features from CT scans to develop an OST prediction model for
pancreatic ductal adenocarcinoma patients [62]. They found the prediction model performs better
with DL radiomic features than other radiomic features. In [61], Priya et al. extracted texture
features from MRI images and added patients’ age to train the OST classifier for GBM patients.
They found NN produced the best prediction model.
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Table 1.1 Survival prediction models based on medical data for various types of tumors.
Type of a medical

Features type

Disease type

Prediction method type

Study

Ensemble SVM

Gupta et al. 2014 [93]

data
EAR

-

Different types of cancers

classifier
CT

Deep features

pancreatic ductal

-

adenocarcinoma

Zhang et al. 2020
[62]

and radiomic
MRI

Radiomic: Texture

GBM brain tumor

NN classifier

Pancreatic Ductal

Cox regression model

Priya et al. 2021 [61]

Clinical: Age
CT

Radiomic: Texture

Adenocarcinoma
CT

Radiomics: statistical,

head and neck squamous cell

morphological,

carcinoma

non-parametric

Attiyeh et al. 2018
[60]
Leger et al. 2017 [59]

regression, and full-

histogram-based and

parametric ML

texture features from
CT

Radiomics and Deep

lung cancer

Classification hazard

Haarburger et al.
2019 [58]

Random Forest

Ali et al. 2021 [94]

learning
MRI

Radiomics: texture, shape,

GBM

intensity, and wavelet

Regressor classifier

features
MRI

Radiomics: shape and

GBM

Linear Regression

Feng et al. 2020 [66]

GBM

Epsilon-Support Vector

Wang et al. 2020 [65]

volume, and non-clinical
imaging
MRI

radiomics and
invasiveness features

Regression, and Random
Forest

MRI

Radiomics: (number of

GBM

Ensemble (Random

tumor cores and number

Forest linear regression)

McKinley et al. 2021
[95]

of tumor components)
clinical features: age
MRI

Radiomics: geometric

GBM

Ensemble ML models

(size and shape),
statistical, texture,
location clinical
information
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Asenjo et al. 2021
[103]

MRI

Radiomics: volumetric

GBM

Linear Regression

Bommineni et al.
2021 [104]

Gallbladder

Random Forest binary
classifier and cox

Zefan et al. 2020
[102]

Various ML methods

Sun et al. 2018 [57].

Binary SVM

Nie et al. 2019 [89]

and location features
Clinical features:
resection status, age
CT

Radiomics: texture
features (GLCM, LLL,
JJJ, MM)

CT

Radiomics: intensity, fine

non-small cell lung cancer

texture, coarse and

(NSCLC)

morphological features
contrast-enhanced
T1, DTI), rs-fMRI

Radiomic: DL features,

HGG

tumor size, histology type
and patients’ age

GBM is the most aggressive glioma brain tumor with the lowest survival rate after diagnosis [14,
15]. Unfortunately, an estimated 24,530 individuals in the United States will be diagnosed with
malignant brain tumors in 2021, and 50% will be GBM tumors [105]. Understanding the behavior
of GBM tumor is essential to improve prognosis outcomes as well as to decide a proper treatment
plan. MRI scans are a gold imaging test to identify the size and location of brain tumors because
of their superior soft tissue contrast which provides better visualization of tumor regions [27, 106].
Thus, various prediction systems were developed based on MRI scans to predict OST for patients
with GBM tumors [65, 66, 89, 94, 95, 102-104]. Based on our knowledge, two multimodal
preoperative MRI datasets have been used to improve prognosis outcomes for GBM patients to
estimate OST based on ML/DL methods [89, 30, 31, 107]. Huashan hospital/Shanghai-China
collected and prepared the first multimodal MRI data [89]. This data is not available to the public,
and it consists of 93 samples (i.e. patients) with HGG. Each sample has three preoperative MRI
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modalities: T1ce, DTI, and resting-state functional MRI (rs-fMRI) [89]. Nie et al. used 68 samples
of this data to train an OST binary classifier that classifies each patient into one of the two survival
time groups: short-survival (< 22 months) and long-survival (≥ 22 months) [89]. Where the
remaining 25 samples were used for validation and test process. The second dataset is Multimodal
MRI scans that were well processed and released by Multimodal Brain Tumor Segmentation
challenge (BraTS) to develop the state-of-the-art-methods to segment glioma brain tumor and to
predict OST for GBM patients [30, 31, 107]. The BraTS survival 2020 dataset consists of 269, 29,
and 107 samples (i.e. patients) with GBM tumors for training, validation, and test processes,
respectively. Each sample in the BraTS challenge has four preoperative MRI modalities: T1, T2,
T1 GD, FLAIR [30, 31, 107]. The BraTS 2020 training dataset is a public available data, which
was released with labels to train and validate a survival prediction system for patients with GBM
tumors. This prediction system classifies patients into three groups of survivors: short-term (<10
months), mid-term (10=15 months), and long term (>15 months). The BraTS 2020 validation and
the BraTS 2020 test datasets are unlabeled, and the BraTS challenge used them to evaluate stateof-the-art OST prediction methods [30, 31, 107]. Both these two multimodal MRI datasets are
small data in terms of number of samples, thus, meaningful radiomic features and traditional ML
methods have been proposed and developed to produce a reliable OST prediction system [65, 67,
89, 95, 108]. As the BraTS validation and test datasets are unlabeled, several DL segmentation
models were developed as an alternative, fast, and inexpensive method to recognize and localize
brain tumors regions in MRI scans. These models segmented glioma brain tumors to extract shape,
size and location descriptors as radiomic features in the preprocessing step [84-88, 108]. Various
strategies and methods were used to produce reliable prediction models, such as feature fusion [92,
103, 108], ensemble models [66, 95, 103], data augmentation and analysis, and feature selection
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methods [105]. Table 1.2 summarizes the top-ranked OST prediction models that achieved the best
predictions in the BraTS 2018-2020. Ali et al. extracted various types of radiomic features,
(texture, shape, intensity, and wavelet features), from the brain tumor segmentation results and
MRI images, and used Random Forest Recursive Features Eliminations (RF-RFE) method to
reduce the size of the feature vector [94]. The selected features were used to train the Random
Forest Regressor (RFR) classifier that achieved 48% and 57% accuracy in the BraTS 2020
validation and test datasets, respectively. Feng et al. used an ensemble 3D deep learning model to
develop a Linear Regression (LR) system for overall survival time [66]. This survival prediction
model is based on clinical imaging features (shape and volume), and non-clinical imaging features
or brain tumors. Agravat et al. used volumetric features for the brain tumor sub-regions, shape
features for necrosis tumor region along with patients’ age and a Random Forest Regressors (RFR)
with 5-fold cross validation to develop an OST prediction system. This combination achieved the
best predictions in the BraTS 2019 with 56.4%, 58.6%, and 57.9% accuracy in the training,
validation, and test BraTS 2019 datasets, respectively [108]. Wang S. et al. collected radiomics
and invasiveness features from the segmentation results, and used them to train the overall survival
time prediction model [65]. The developed model based on invasiveness features achieved the
second place in the BraTS 2019 challenge. McKinley et al. proposed two simple radiomic features
that were derived from the segmentations of the brain tumor subregions, number of tumor cores
and number of tumor components, combined with patients’ age to train a random Forest (RF) ML
models to achieve the best OST predictions in BraTS 2020 [95]. They used an ensemble model of
LR model and RF classification model in the BraTS 2020 validation and test dataset. Their
ensemble model achieved cross validation and test accuracy 53% and 61.7%, respectively. In
[103], Asenjo et al. used feature selection methods to select rubout descriptors from different types
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of radiomics features (geometric (size and shape), statistical, texture, location, and clinical
information); the new set of features were used to train different ML classification and regression
models features vector; their ensemble model achieved validation and test accuracy of 51% and
61.7%, respectively, to achieve promises predictions in BraTS 2020. In another study, Bommineni
et al. extracted volumetric and location features of the GBM brain tumor and combined them with
resection status and patients' age to train an LR model; their model performed badly in the
validation dataset (with 37.9% accuracy) compared to the 58.9% in the test set [104]. As listed in
Table 2.1, the best classification accuracy for OST systems based on three classification survival
time terms does not exceed 62%. Some studies found that the low accuracy of the OST
classification model for GBM patients was improved when binary classifier, short-term vs longterm, is used instead of multi-class classifier [64, 109-111]. To develop OST prediction system
based on a binary classification task (short-survivors (≤12 months) vs. long-survivors (>12
months)) using BraTS 2018 dataset, Xu Y. et al. used ML methods and different types of features
(radiomics features, nomogram, ependymal and piamater involvement (EPI)), along with patients’
age [109]; the nomogram features achieved the best classification performance with 87.8%, 87.5%,
and 85.8% accuracy on the train, test, and external validation sets, respectively [109]. In another
study [110], Macyszyn et al. developed two binary classification models, short-survivors and longsurvivors, using SVM and radiomic features (shape, location, intensity) for patients with GBM
tumors; the threshold classification time was six months and eight months for the first model and
the second model, respectively. The first classifier achieved a cross validation accuracy of 87.62%
in the training dataset and 82.76% in the test dataset. While the second classifier achieved a cross
validation accuracy of 88.57 % in the training dataset and 83.33% in the test dataset. They
concluded that the second classification model achieved better accuracy than the first classification
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model. In [111], a Decision Tree (DT) binary classifier was developed based on multimodal MRI
radiomic and clinical information to classify an HGG patient into either short-survivors group (≤18
months) or long-survivors group (>18 months); the authors used a dataset that consists of 67
patients of the HGG. When 18 patients are with anaplastic gliomas, 56 patients have GBM, and 1
patient is with GBM. The authors reported that their OST prediction model based on ML provided
a better predictor of prognosis with 85.1% accuracy in HGG than pathologic classification. In sum,
the performance improvements that were achieved by binary classifiers they can be due to more
samples being used in each class in the training process, and less correlated information or features
between classes. We conclude from Table 1.2 that the volumetric, location, and shape features are
meaningful descriptors to develop an efficient OST prediction model for patients with GBM
tumors [65, 67, 94, 104, 108, 112-114]. To extract this type of features for the OST prediction
classifier, DL Segmentation models were developed and tested [65,88, 112, 115-126]. Table 1.3
summarizes the best segmentation models in BraTS 2017-2019 datasets. Various useful strategies
were proposed and developed to produce efficient segmentation models for glioma brain tumor
using BraTS datasets, such as multi-scale patches [115], large input patches [88, 120, 123, 125],
ensemble models [12, 116, 120-124], cascaded nets [119, 123], semi-supervised [124], new
loss/multi-loss function [12, 124], residual blocks [88, 121, 123], and tumor overlapped region
optimization [123], etc. Zhao et al. [115] proposed an automatic brain tumor segmentation method
based on multi-scale CNN. The authors found that their proposed method improved the results of
tumor segmentation compared to using a single scale input patch. Kamnitsas et al. achieved the
top rank submission in the BraTS 2017 challenge [116] due to their segmentation of glioma brain
tumor sub-regions. They proposed an ensemble of several efficient segmentation models such as,
U-net [84], DeepMedic [117], and FCN [118].
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When each of these models was trained

independently to segment glioma brain tumor sub-regions and then the prediction results of these
models were averaged to produce the final decision based on the ensemble method. Wang et al.
[119] achieved the second rank in the BraTS 2017 challenge by training three cascaded identical
networks based on a deep and complex encoder part, followed by a simple decoder part. The first
DL model was used to segment an entire brain tumor from preoperative multimodal MRI scans,
and the results were feed to the next DL model which was used to segment the tumor core
subregion. Then the segmentation results of the tumor core were used as inputs for the last DL
model to extract the enhanced tumor (ET) subregion. In another study, the Encoder/decoder
convolutional neural network based on Residual blocks was combined with a variational autoencoder branch to overcome dataset limitation and to improve segmentation results of glioma brain
tumor sub-regions [88]. The variational auto-encoder branch is used to reconstruct image input
itself and the L2 loss was combined with soft loss to be minimized to improve prediction
performance. This combination with large patch size achieved the best segmentations in the BraTS
2018 challenge. The Encoder/decoder part is like U-Net but with Residual blocks and long skip
connections based on element-wise addition instead of concatenation paths which allowed to
increase the value of high-level features. In [120], Isensee et al. proposed a modified U-Net with
a large patch size as an efficient model to segment glioma brain tumor sub-regions. The
modification on U-Net includes large patch size, Leaky Rectified Linear Unit (LReLU)
nonlinearity activation functions, batch normalization between a convolutional layer and LReLU,
which increased the quality of the features. In addition, the authors used soft Dice Loss (DL) and
Cross Entropy Loss (CE) to enhance the segmentation decisions. This proposed method tested on
validation-independent BraTS dataset and achieved second place in the BraTS 2018 challenge for
segmentation task. Ensemble deep learning models have been proposed to improve performance
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of a segmentation system in the decision-making step instead of building a new complex deep
structure [65, 112, 116]. Xue Feng et al. ensembled six deep learning 3D U-Net models to develop
an accurate brain tumor segmentation model [112]. These models differ in the input patch sizes,
number of U-Net Encoder/Decoder stages, and type of Loss function [112]. The proposed
ensemble model has been used to develop an LR OST prediction system. The segmentation model
performed perfectly and ranked 9th in the challenge. However, the authors believed that they can
achieve better performance when using larger patch sizes to train a prediction model. Wang S. et
al. developed an ensemble deep learning model based on combining state-of-the-art convolutional
neural network models of brain tumor segmentation to predict the overall-survival time [65]. The
proposed segmentation models were based on U-Net with large batch sizes (96 and 128) and
different Loss functions (CE and Soft Dice).
In sum, most of the top-ranking brain tumor subregion segmentation models are based on
U-Net DL structures with minor modifications such as large patch sizes, ensemble approaches,
different activation functions, different loss functions, multi-loss functions, and different numbers
of encoder/decoder stages. The U-Net is a common deep learning medical image segmentation
structure that efficiently deals with small datasets [84, 112, 126, 127]. Its convolutional structure
consists of an asymmetric structure of multi-encoder/decoder units with concatenation paths to
combine low level features from the contracting path with high level features from the expanding
path for precise localization. Therefore, a modified U-Net structure has been proposed in this work
to develop an accurate brain tumor subregion segmentation model which will be used to develop
the overall survival time prediction model. In addition, the volumetric features that were collected
from segmentation results are important to develop overall survival time predictions.
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Table 1.2 State-of-the-art overall survival time prediction methods for Glioblastoma patients
using BraTS 2018-2020 datasets, where RS refers to the resection status and Acc refers to the
accuracy.
Study
(Rank-Year)

Features

Feng et al.

Radiomics (volumetric, shape)

(1st 2018) [112]

+ (age, RS)

Puybareau et al.

Radiomics (size, location)

(2nd 2018) [113]

+ age

Baid et al.

Radiomics (shape,

(3rd 2018) [114]

statistical, texture) + age

Agravat et al.

Radiomics (shape, statistical

(1st 2019) [108]

texture) + age

Wang S. et al.
(2nd 2019) [65]

Wang F. et al.
(3rd 2019) [67]
McKinley et al. (1’st,
2020) [95]

Validation

Test

Acc

Acc

Linear regression

32.1%

-

Random forest

54%

61%

Neural network

57.1%

55.8%

Random Forest regressor

58.6%

57.9%

59%

-

44.8%

55.1%

53%

61.7%

37.9%

58.9%

48%

57%

ML Model

Radiomics (shape, location,
texture features) + invasiveness +
(age, RS)

Random Forest, epsilonsupport vector regression

Radiomics (volumetric, shape) + Fully connected neural
network with two hidden
age
layers
Radiomics (number of tumor

Ensemble (Random

cores and number of tumor

Forest and Linear

components) +Age

Regression)

Radiomics (volumetric and
Bommineni et al. (2’nd,
2020) [104]

location features)

Linear Regression

+ (RS+ age)

Ali et al. (3’rd, 2020)

Radiomics (texture, shape,

Random Forest

[94]

intensity, and wavelet features)

Regressor classifier
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Table 1.3 The-state-of-the-art segmentation methods in BraTS 2017- BraTS 2019.
Rank
1

2

Study (year)

DL Segmentation Model (Descriptions)

Patch size

Kamnitsas K. et al.

Ensemble ((U-Net (element-wise addition instead of

64*64*64*4

(BraTS 2017) [116]

concatenation), DeepMedic, and FCN)

Wang G. et al.

U-Net: three cascaded identical networks.

-

Modified U-Net (Encoder: short connections-residual

128*128*128*4

(BraTS 2017) [119]
3

Isensee F. et al.
(BraTS 2017) [126]

1

Myronenko A. et al.
(BraTS 2018) [88]

2

Isensee F. et al.
(BraTS 2018) [120]

2

3

Encoder/Decoder CNN (Residual blocks) was combined +

Modified U-Net (instance normalization, leaky ReLU , 4

[121] (BraTS 2018)

dense block, Ensembled)

Zhou et al. [122]

Encoder/Decoder (concatenation paths and residual

Jiang et al. [123]

•

(BraTS 2019)

128*128*128*4

levels, Ensemble 5 models)
DeepSCAN: Modified U-Net (Densnet block and Dilated

•

160*192*128*4

Variational Auto-Encoder

McKinley R. et al.

(BraTS 2018)
1

block, and decoder: localization block) + Dice loss)

192*192*5

32*32*16*4

blocks, Ensemble 2 models)
Two-stage cascaded U-Net

128*128*128*4

(pre-activated residual block, Ensemble models, soft dice
loss for overlapping brain tumor regions instead of labels,
adding loss of two stages)

2

Zhao et al. [124]
(BraTS 2019)

self-ensemble U-Net model (simi-supervised technique,
two model fusing methods (ensemble models, and fusing
of overlapped patch, Loss summation of cross-entropy and

-

average dice loss
3

McKinley et al [12]
(BraTS 2019)

Modify DeepSCAN (instance normalization, lightweight
local attention mechanism, focal loss to avoid data
imbalance, ensemble models)
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192*192*5*4

1.3 Motivations and Contributions
Medical diagnosis errors and improper medical treatment methods negatively affect
patients’ health. Diagnosing fatal disease, such as GBM brain tumors is a costly and timeconsuming task that makes patients carry an additional burden to their health. Recently, various
research ideas involved ML/DL methods in the healthcare system to enhance the diagnosis process
as well as to improve patients’ health. Understanding tumor behavior is crucial to decide a proper
treatment plan, which is essential to improve prognosis outcomes, as well as patients’ health. In
this dissertation, we thus focus on using ML to improve the GBM brain tumor diagnosis in terms
of cost, time, and accuracy.
This dissertation’s main objective is to develop a Computer-Aided-Diagnosis system
(CADiag) to estimate automatically the overall survival time (OST) for patients with GBM brain
tumors using medical imaging data (mpMRI scans) and clinical non-imaging data (patients’ age,
survival time and resection status). To understand the tumor behavior, this dissertation focuses on
developing an automatic OST prediction system based on a classification task for patients with
GBM brain tumors. We proposed several hypotheses to develop an automatic OST prediction
system based on the BraTS dataset. The hypotheses that developed this dissertation and the main
contributions are illustrated below:

1.3.1 Hypotheses
The following hypotheses were proposed to develop this dissertation:
1. To develop an OST prediction system for patients with GBM tumors, a proper dataset is
required. Based on our knowledge, the BraTS dataset is the best well-processed and labeled
medical data to develop the-state-of-the-art segmentation methods for glioma brain tumor sub19

regions [30, 31, 107]. The BraTS challenge also released survival data along with imaging data
to develop the-state-of-the-art OST prediction methods for patients with GBM brain tumors
[30, 31, 107]. The size of the survival BraTS training dataset is small in terms of the number
of samples. BraTS 2020, for example, has only 269 samples (i.e., patients). This data consists
of medical imaging data, and clinical non-imaging data. The medical imaging data contains
four preoperative MRI scans, and each of these scans is a 3D MRI image [30, 31]. The clinical
non-imaging data consists of the patients’ age, survival time, and resection status [31].
Recently, most researchers use DL to develop efficient prediction models rather than
traditional ML, due to its supremacy in terms of prediction accuracy [75-77]. In fact, DL
methods are able to develop numerous robust global and local descriptors to describe complex
nonlinear patterns in data if large data in terms of number of samples is available [80]. ML
methods achieve better performance than DL when small/medium data in terms number of
samples is used in developing prediction models [58-62]. As the size of this data is small, we
proposed and developed various OST prediction models based on ML methods.
2. Each MRI scan in the BraTS imaging data contains of volumetric information of a brain with
glioma tumor, and its size is 240 x 240 x (155 slices) [30,31], which means the size of a single
MRI scan is too large to train an ML prediction model directly. We therefore propose and
develop meaningful information, called radiomics features, to be extracted from MRI scans in
the preprocessing step to train the OST prediction system.
3. Although there are risk factors related to developing a brain tumor [128], the main cause is still
unclear. In order to develop an accurate OST prediction model for GBM patients based on
ML, we propose using different types of information, such as various radiomics features and
non-imaging features.
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4. The size and location of GBM are identified as factors relating to patients’ survival rate [129,
130]. Some research studies identified the relation between the appearance of a specific brain
tumor subregion with survival rate [130, 131]. Therefore, radiomics features based on shape,
volume, and location information of GBM tumor subregions have been proposed and
developed to train the OST prediction system.
5. The color variations in structural MRI scans present tissue contrast in the brain to visualize
normal and abnormal tissues. Texture features in an image are related to the study of pixel
density variation [132]. We thus proposed texture features to develop the OST prediction
system. We also propose using histogram distributions from MRI images for each patient as
radiomic features to train the OST prediction system. When the histogram distribution is
another way to understand the pixel densities in MRI images.
6. Various studies investigated the relation between the survival rate and the patient’s age [18,
19, 49, 133], and the survival rate and the patient’s resection status [131] for patients with a
GBM brain tumor. We thus combined the patients’ age and resection status as non-imaging
features with the radiomic features to increase the quality of the training data. We believe this
combination able to improve the performance of the OST prediction system.
7. Single type of features could not be enough to describe the prediction system. We therefore
use feature fusions in the preprocessing step to combine different types of radiomic features,
as well as radiomic and non-imaging features. We also propose using feature selection
methods to improve the accuracy for the OST prediction system by selecting robust features.
8. Neuroradiologists must label brain tumor sub-regions in MRI scans to extract volumetric,
location and shape information [30, 31]. However, involving experts in labeling MRI images
is a time-consuming and expensive process. We therefore propose and develop a DL
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segmentation model as an alternative, fast, and inexpensive method to extract this information
from MRI scans.
9. Based on the literatures and Table 1.3, most high-ranking researches in the segmentation task
of the BraTS challenge developed DL segmentation models based on a modified U-Net
because of its ability to achieve accurate predictions in small complex segmentation data [116,
119-121, 123- 125]. This excellence in segmenting the glioma brain tumor sub-regions is due
to the concatenation paths in the U-Net that combine low-level features from decoder units
with high-level features in the corresponding encoder units. We thus propose and develop a
novel structure based on a modified 3D U-Net that processes 3D multimodal MRI scans. Our
modifications focus on increasing the quality of the high-level features by improving low-level
features, so we developed an accumulated encoder unit that extracts valuable low-level features
by combining features from two different branches in the encoder unit. We use different
kernels in each of these branches to generate different features. This modification achieves a
promising segmentation in the BraTS 2020 datasets [137]. We use this segmentation model to
extract the brain tumor sub-regions in the unlabeled BraTS 2020 datasets to derive the
proposed radiomic features based on shape, location, and size information, which we use in
predicting the OST for patients with GBM brain tumors.
10. The BraTS segmentation data is unbalanced as the size of any brain tumor sub-region is
relatively small compared to the size of the brain. We therefore propose two methods to deal
with unbalanced data in the segmentation task. In the first method, we used a balanced batch
selection in the preprocessing step to prepare proper training patches from Multimodal
preoperative MRI (mpMRI) scans that contains all brain tumor sub-regions for training the
segmentation model. We selected patches size 64×64×64 to deal with hardware limitations
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from the four MRI scans that contain all the four segmentation labels. In the second method,
we propose and use the generalized dice loss function in training the DL model to overcome
unbalanced data labels.
11. MRI scanners add noise to the raw MRI data [134, 135] affecting the quality of MRI
information. We thus propose a denoising process in the preprocessing step to remove the
noise, and to improve the quality of the data, as well as histogram features. We believe
enhancing the quality of these features improves the performance of the OST
prediction model.
12. To produce the best OST prediction system based on various radiomic feature, non-imaging
features, and ML methods, we develop many prediction models. We propose using system
accuracy, and an individual class accuracy, to select the best prediction model. In addition, we
propose using the ensemble modeling technique of high-performance prediction models to
improve the performance of the OST prediction system in the decision-making stage. We thus
propose involving the ensemble modeling technique in the post-processing step to improve the
OST prediction system accuracy.

1.3.2 Contributions
The main contribution of this dissertation is a CADiag was developed to predict the OST
for patients with GBM tumors. The OST prediction system automatically estimates the OST for
patients with GBM tumors from mpMRI scans and clinical non-imaging, which is important to
increase the understand of the tumor behavior. This system contains a segmentation sub-system
based on a DL method to automatically detect the GBM tumors, and extract the brain tumor subregions from mpMRI scans. We propose to use this system as a CADiag assistant method to
support and improve the medical decision making, as well as to accelerate the diagnosis process,
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especially, it automatically provides predictions (decisions) without any additional costs. We
found that the OST prediction system based on shape, volume, and location features achieved
remarkable predictions in terms of the overfitting in the BraTS 2020 challenge. To develop a
reliable fully automatic OST prediction system, the following methods were developed and
validated from the perspective of ML methods:
1. We proposed, developed and evaluated four novel radiomic feature extraction methods using
the BraTS 2017 dataset to develop an efficient automatic OST prediction system for patients
with GBM brain tumors. These features are volumetric, location, texture, histogram, and DL
[64, 136].
2. We proposed and evaluated two different novel methods to extract volumetric and location
features [64, 137]. The first method was developed using the BraTS 2017 dataset, and it is based
on calculating the ratio of the WT region to the whole brain region, and the ratios of different
brain tumor sub-regions to the WT region [64]. The second approach was developed using
BraTS 2020 dataset, and it is based on calculating the volumes of a brain, WT, and tumor subregions in different brain sub-volumes based on a brain functionality structure [137, 138]. We
found adding non-imaging features to the radiomic vector boosts prediction results.
3. We calculated shape features for both whole brain tumor region and tumor core region in MRI
scans. The non-imaging features were added to the shape features to train an efficient OST
classifier. This classifier achieved remarkable predictions in an unseen validation BraTS 2020
dataset compared to a classifier based on volumetric features [137].
4. To improve the performance of the OST classifier, three types of information fusions methods
were used and tested: multi data fusions, feature-level fusions, and decision-level fusions. In
data-level fusions, we combined imaging data with non-imaging data to increase the meaning
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of the data as well as to improve the prediction accuracy [64, 136-138]. In the feature-level
fusions, we integrated different types of radiomic features to boost prediction results of the OST
system by increasing the quality and value of radiomic information [64, 137]. We also
performed decision level-fusion by using ensemble modeling technique to enhance prediction
rates by integrating multiple diverse models [137]. These techniques boost system accuracy in
unseen BraTS 2020 datasets [137].
5. The histogram distributions of The MRI scans in BraTS datasets shows that imaging data
contains Rician noise or non-central Chi noise. We proposed and used denoising Discrete
Wavelet Transform (DWT) to improve the quality of MRI scans, as well as to increase meaning
of the histogram features [136]. The denoising method improves the performance of the OST
classifier based on histogram features [136].
6. Some proposed radiomic features were extracted directly from MRI scans such as texture
features, histogram-based features, and DL features [64, 136]. Experts must localize and
identify the brain tumors in an MRI scan, relying on features based on size, shape and location
information of the glioma brain tumor. 3D DL segmentation models based on U-Net structure
were thus developed to extract glioma brain tumor sun-regions in MRI scans automatically
[137]. Then the volumetric, shape, and location features were computed from the segmentation
results. This segmentation model was used to extract shape, volumetric, and location features
from an unseen validation dataset to test and evaluate our proposed OST prediction system.
7. We proposed and developed a Modified 3D U-Net DL structure based on the accumulated
encoder units to improve the performance of the glioma brain tumor segmentation model. This
segmentation model enhanced the segmentation predictions by increasing the quality of low-
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level features in the encoder branch, which improved the meaning of the high-level features in
the decoder branch [137].

BraTS data
MRI Scans + Clinical Data

Preprocessing
DL segmentation model, Denoising, Feature Fusions, Thresholding

Radiomics Features
Shape, Location, Volume, Texture, Histogram, Deep Learning Features

Machine Learning Algorithms
SVM, NN, RF, LR, KNN, Tree

Test and evaluation
Accuracy, Confusion Matrix, Area Under Curve

Results
Overall Survival Time Predictions

Figure 1.1 Steps to develop Overall Survival Time prediction system
for GBM patients.
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1.4 Dissertation Outline
This dissertation consists of five chapters and two appendixes. The first chapter is the Introduction,
and the other four chapters are as follows:
Chapter 2, “Automatic Overall Survival Time Prediction System for Glioblastoma Brain Tumor
Patients” presents the steps and data to develop a fully automatic OST prediction system based on
a classification approach.
Chapter 3, “Methods” presents and explains the proposed methods, which include features
extraction methods, and DL segmentation model to develop the OST prediction system. In
addition, we present and clarify strategies to improve the performance of the OST prediction
system, such as denoising process.
Chapter 4, “Experimental Results and Performance Evaluations” presents the experimental
results of the survival prediction system using the BraTS 2017, 2019, and 2020 datasets.
Chapter 5, “Conclusions and Future Work” concludes this dissertation, highlights and discusses
its achievements, and suggests directions for future work to improve the performance of the
proposed OST prediction system.
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Chapter 2- Steps to Develop an Automatic Overall Survival Time Prediction
System for Glioblastoma Brain Tumor Patients

2.1 Introduction
The Predictive Analytics Process (PAP) is used in the healthcare industry to improve
diagnosis outcomes and treatment decisions in a timely manner based on modeling and estimation
techniques [139, 140]. The term predictive analytics simply refers to use statistical techniques
and ML algorithms including traditional ML and DL methods to describe the possibility of future
outcomes depending on available history data. The substantial goal of using the PAP in the
healthcare system is to improve patients’ health by improving understanding of diseases behavior,
enhancing patient care quality and program analysis, and developing methods for drug discovery
and development analysis [141, 142]. The PAP consists of five main steps to develop efficient
automatic prediction systems in healthcare, as shown in Figure 2.1. These steps are objective, data
collection, preprocessing, modeling, and monitoring.
In this dissertation, the PAP is involved to develop an efficient automatic OST prediction
system for patients with GBM tumors by using ML/DL prediction techniques. Develop effective
and functional prediction systems in the medical field requires proper datasets and effective
artificial intelligence estimation algorithms. In fact, predictions in the medical field are challenging
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due to difficulties in collecting and preparing adequate medical data that contains meaningful and
effective attributes to develop a prediction model [44, 143]. Deciding a proper ML/DL method, as
well as tuning model’s parameters is also a complex task [44, 45, 144, 145]. Moreover, sometimes
more processing methods are required to boost the performance of a prediction system, like
preprocessing methods which include data analysis and image/signal processing methods [146],
and postprocessing methods such as images filtering enhancements and ensemble models for final
decision-making.
This chapter demonstrates the five steps of PAP to develop any prediction systems in
healthcare. It also clarifies in details how these steps are aid in designing, developing, and
evaluating a fully automatic efficient OS prediction system for patients with GBM brain tumors
based on medical imaging data and clinical data.
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Figure 2.1 Structure of PAP to develop automatic prediction systems.

2.2 Objective
Objectives and questions within medical studies play a fundamentals role in designing a
new research protocol. Conceptualizing and developing a research idea relay on the following
seven substantial/primary steps [147]:
1. Identify decisions, decision makers, actions, and context.
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2.

Synthesize the current knowledge base.

3. Conceptualize the research problem.
4.

Determine the stage of knowledge development.

5. Apply populations, interventions, comparisons, outcomes, timeframe, and settings (PICOTS)
framework.
6. Discuss evidentiary need and uncertainty.
7. Specify the magnitude of effect.
Recently, many research investigations in the medical field have involved AI methods to
improve patients’ health and reduce their suffering. The type of medical data, type of learning
algorithms, and type of evaluation measures are specified and selected in any research
investigations based on a research’s objectives. Usually the type of study data has been decided
in this step. In general, involving ML and DL techniques in medical research investigations seeks
to improve the healthcare system based on the following:
1. Improving the diagnosis process and prognosis outcomes. For example, there are about 75%
serious diagnosis errors result from missed vascular events, infections, and cancers [68, 148].
Recently, Hollon et al. involved the Artificial Intelligence (AI) based on DL to develop a tissueto-diagnosis pipeline nearly online processing to accurately classify brain tumor tissues into
thirteen histologic categories [149].
2.

Deciding a proper treatment plan. Diverse research studies have been conducted and
developed to improve the treatment planning process, such as treatment planning automation,
treatment knowledge-based planning, and the multicriteria treatment planning optimization
[72-75]. For example, an ML based on the RF algorithm was developed and evaluated for
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therapeutic curative-intent radiation therapy treatment planning for prostate cancer patients
with full integration into the clinical workflow [74].
3. Improving drug discovery and development. For example, DeepBAR is a DL model that
designs drug molecules’ binding affinity to proteins [69], and a developed prediction system
using SVM with genomic data to categorize proteins into drug targets and non-drug targets for
pancreatic, ovarian, and breast cancers [70].
4.

Improving early disease detections. The non-motor features of sleep behavior disorder and
olfactory loss, along with significant biomarkers (Cerebrospinal fluid [CSF] measurements and
dopaminergic imaging markers), were used for early diagnosis of Parkinson’s disease based
on ML prediction methods [150].
The main goal of this dissertation, as mentioned in chapter one, is to develop an efficient

OST prediction system for patients with GBM brain tumors. The OST prediction system is
produced to better understand the behavior of this aggressive type of brain tumor which is
important to support treatment planning process. This prediction system estimates prognosis
outcomes by categorizing a GBM patient into one of the following three groups: short-survivors
(< 10 months), mid-survivors (10-15 months), and long-survivors (>15 months). To develop this
prediction system, we decided to used multimodal medical data, such as imaging data (mpMRI
scans), clinical non-imaging data (age and resection status), and genomic data. We use mpMRI
data because it is one of the diagnosis tests to identify the size and location of GBM brain tumors.
We also involve patients age and resection status information, because research investigations
proved their relation to the overall survival time rate [18, 19, 49, 131, 133]. In addition, we planned
to include genomic data as some investigations highlighted its effectiveness on estimating survival
time predictions [151, 152].
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2.3 Healthcare Data Collection
Collecting proper medical data is the second step of the PAP, after defining the objective,
and it is an essential step to develop an efficient prediction system. In general, Health data refers
to information produced and stored, not only by healthcare provider and organizations, but also
health-relevant data that are gathered from individuals and entities using other resources. These
include healthcare system (electronic medical record data, medical images laboratory, data
radiography laboratory data, etc.), consumer health and wellness industry (fitness tracking devices,
health monitoring apps, surveys outcomes that were reported by patients, etc.), digital information
such as daily activities (social media posts, Internet search histories, etc.), and non-health
demographic, social, and economic sources (race, gender, income, credit history, etc.) [ 146, 153].
Availability of proper data is a crucial key to develop an efficient prediction system based on
ML/DL methods for healthcare applications. However, providing proper medical data is
sophisticated task, and the main challenges include data structure, such as incompatible formats
and large volumes, data standardization, such as data acquisition and cleansing, security, such as
privacy and confidentiality, storage and transfer, such as expensive to store, and managerial skills,
such as governance and ownership issues [143].
Recently, various ML/DL methods have been involved in the medical field to perform
complex prediction tasks based on medical data [154-157]. DL algorithms are the most common
prediction methods due to their superior estimation accuracy compare to ML algorithms. However,
collecting and preparing proper medical data for DL poses several challenges, as DL algorithms
need a large amount of data in terms of the number of samples to train and evaluate reliable
prediction models [80, 158]. Rather than using DL algorithms, ML are proper when big data are
not available [159, 160]. Nevertheless, extracting suitable type(s) of engineering features
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especially from imaging data, is still challenging to develop a reliable prediction model [159, 160].
The following points highlight the main challenges of medical data for automatic prediction tasks:
a. Medical research data privacy and sparsity: medical research data is personal data related to
patient’s health. In general, accessing data produced by the healthcare system is still difficult
as the goal is to protect public health, to underpin discoveries, or to expand the evidence base
for health and wellness interventions [153].
b. Limited data availability: medical data is often highly limited in size and quality due to sparsity
of patient contact, variability in medical care, and privacy concerns [161]. Most medical
decisions on various medical tests and exams, meaning that different types of medical data
must originate from various resources and devices. In addition, medical decisions and
estimations of patients’ situations do not depend on a single factor, but generally on multiple
factors, including age, gender, daily habits, environmental factors, family genes, etc. Using a
single type of data exclusively cannot produce an accurate ML/DL prediction model.
c. Imbalance and bias data: most of medical data are highly imbalanced and biased due to various
resources and institutions that provide and collect medical data for various research goals. For
example, imbalanced gender in medical imaging data produced biased prediction models.
There are three common medical information biases: self-reporting bias, measurement error
bias, and confirmation bias. To overcome or reduce each of these data bias types, crucial
planning is needed in each step of the research design [162]. As medical data contains broad
information that requires huge storage sizes, specific information types are mostly gathered for
a single research goal or idea. To generate an accurate prediction model, collecting medical
data from different institutions and medical centers to increase its size becomes necessary.
However, multi data resources leas to medical data with different distributions, which is
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sometimes hard to be processed and generalized for a research idea. This results in imbalanced
data that either contains redundant information, misses valuable information, has imbalanced
factors, and/or data in different formatting types and distributions.
Due to these limitations, well processed and analyzed publicly available medical data have
been used commonly by researchers, such as The Cancer Genome Atlas (TCGA) which provides
molecular and clinical information for more than 30 cancers types [163, 164]. Furthermore, a
single institution data resource is adopted by some research groups to reduce data bias and
imbalance issues. The preprocessing methods are involved as a data preparation step before
training a prediction model to annotate the data for automatic prediction systems, as well as to
provide generalized data that can be used for various research purposes. Medical data
generalization, however, is still challenging, time-consuming and expensive, simply because it is
difficult to manipulate missing information in medical datasets, and it is required experts. To
overcome some medical data limitations that are listed above, various preprocessing methods have
been proposed.

2.3.1 MRI Images
MRI is a medical imaging technique that creates detailed 3D images of organs and tissues,
such as human brain, spinal cord, or vascular autonomy, by using a magnetic field and generated
radio waves. The MRI plays significant roles in the diagnosis and prognosis of patients with brain
diseases such as disorders (stroke, traumatic brain injury (TBI), multiple sclerosis and epilepsy)
[165-167], Alzheimer's disease (AD) [168-170], and tumors [171-173]. Most of the MRI scanners
are tubed shape, as shown in Figure 2.2.
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Figure 2.2 MRI scanner [174].

The human body contains mostly water. Water molecules (H2O) contain hydrogen nuclei
(protons), which become aligned in a magnetic field. An MRI scanner applies an extremely strong
magnetic field (0.2 to 3 Teslas), which aligns the proton "spins" and produces a radio frequency
current that creates a varying magnetic field. The protons flip their spins when they absorb the
energy from the magnetic field. When the field is turned off, the precession process (protons
gradually return to their normal spin) happens producing a radio signal measured by scanner's
receivers to create MRI images.
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There are two different common types of MRI images: structural MRI images, and
functional MRI images (fMRI). Based on biological considerations, structural MRI imaging
provides static anatomical information, whereas functional imaging provides dynamic
physiological information [175]. In general, structural MRI provides qualitative and quantitative
information of different tissues such as shape and size. While the fMRI measures brain activity by
detecting small changes associated with blood flow [176]. The blood flow is increased in the active
brain region. Therefore, structural MRI identifies and localizes abnormal tissues and changes in
the brain such as tumor growth, as well as the integrity of white matter and gray matter regions.
While, the fMRI measures cognition clinical applications such as surgical planning, for monitoring
treatment plan outcomes, and as a biomarker in pharmacologic and training programs.
Different types of structural MRI sequences (modalities) can be generated based on
changing the sequence parameters, Repetition Time (TR) and Echo Time (TE), to visualize
different tissues and detect abnormalities. The structural MRI sequences that are commonly used
in diagnosing the GBM are T1, T2, T1ce, and FLAIR [106]. The T1, T2, and FLAIR are generated
by applying short TR and TE, long TR and TE, and very long TR and TE, respectively [177].
Table 2.1 lists the characteristics and differences between the three MRI modalities T1, T2, and
FLAIR. To improve the visualization of normal and abnormal tissues (such as tumors) in T1 MRI
images, a contrast agent “Gadolinium” is injected into a hand or wrist vein. The produced T1 MRI
image after injecting the patients with Gadolinium-based agent is known as the T1-weighted
Gadolinium contrast (T1 Gd). However, some references refer to the contrast enhanced T1 as cT1,
without mentioning the enhancement agent [178]. Figure 2.3 shows the four MRI modalities (T1,
T2, T1 Gd, and FLAIR) for a patient with GBM from BraTS dataset [30, 31, 107].
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Table 2.1 Characteristics of different structural MRI sequences [184, 185].
Colors in MRI images
Group

Type

TR

TE

(Signal intensity)

Black
No signal

T1

500

14

Spin echo

Dark gray
Low signal

4000

90

CSF

Calcium

Edema

Blood

Dense bone

Most lesions

Flow

Gray matter

Gadolini
um (Gd,
contrast)

FLAI
R

9000

114

Fat

Fat

Fluid
CSF

Calcium

White matter

Edema

Dense bone

Muscles

Most lesions

Flow

Inversion
recovery

White matter

White
High
signal

Air

Air
T2

Bright gray
Intermediate
signal

Gray matter

Air

CSF

Edema

Calcium

White matter

Gray matter

Dense bone
Flow
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Fat

Native T1-weighted

Post-contrast T1-weighted

T2-weighted

T2 Fluid Attenuated Inversion
Recovery (FLAIR)

Figure 2.3 MRI modalities for a patient with GBM brain tumor from BraTS dataset
[30, 31, 107].
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2.3.2 Glioma and Structural MRI Modalities
MRI scans are the best imaging technique to recognize the size and location of brain
tumors, such as glioma, due to their superior soft tissue contrast, which allows the complexity and
the heterogeneity of the tumor lesion to be better visualized than a CT scan [27, 106].
Glioma brain tumors, including GBM tumors, have variable prognosis and heterogeneous
histological sub-regions, and the substantial heterogeneity of gliomas affects their imaging
phenotype [30, 180, 181]. The GBM subregions include peritumoral edema, necrosis, cysts, and
enhancement tumor [182]. Due to poor survival rate and prognosis outcomes of GBM patients,
various clinical studies were conducted to investigate the relation between glioma tumor
subregions and the patient’s prognosis outcomes [129, 130, 133].
Peritumoral edema is defined as a characteristic feature of malignant glioma regarding to
the extent of neovascularization and to vascular endothelial growth factor (VEGF) expression
[133, 183]. Necrosis is a tumor region that represents tissue death in cancers and it commonly
exists with poor survival rate [184]. Chronic ischemia is recognized to be a cause of developing
Necrosis [185]. A study proposed that metabolic stress and inflammation, such as ferroptosis, are
reason tumor necrosis develop [186]. However, the underlying nature and mechanisms driving the
involved cell death are still obscure [184, 185]. Wu et al. concluded from their study that patients
with major edema and necrosis had shorter survival rates [182]. The peritumoral edema was
recognized in T2 scan as very bright signal surrounding the tumor, whereas necrosis was
recognized as a region had a high signal on the T2 scans, but a low signal on the T1 scan images
with an irregular enhancing border on the T1 contrast-enhanced scans. The cyst was defined as a
rounded region that appears as a low signal on T1 scans and very high signals on T2 scans, and
the contrast enhancement in tumors was grouped as “not obvious” when the enhancement signal
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is less than the fat signal, and “obvious” when the enhancement signal is similar to the fat signal
[182]. In general, the edema appears as a bright region (high signal) surrounding the necrosis in
both T2 and FLAIR scans but the necrosis can be recognized as a high signal (bright) and a low
signal (dark) in T2 and FLAIR, respectively [177]. Table 2.2 lists the visibility of tumor subregions in different structural MRI scans. We concluded, it is essential to use different structural
MRI modalities to find accurate size and location information of the glioma brain tumor
subregions. Figure 2.5 shows the visibility of glioma brain tumor sub-regions in different structural
MRI modalities [30]. Seidel et al. studied the relationship between the patient’s prognosis and the
following three factors: extent of peritumoral edema and VEGF expression, size and location of
the necrosis, and patients’ age [133]. The authors used the T2 contrast scan to recognize the edema,
and compared the T1 scan with T1 contrast to recognize the necrosis region. They concluded from
this study that patients’ age at diagnosis is not related to the degree of peritumoral edema, and
tumors located in the white matter correlate with greater extent of edema. In addition, they found
the volume of necrosis reflects the size of edema. Other studies investigated the relation between
the survival rate and the appearance of cystic component [130, 187, 188]. Cysts commonly occur
in low-grade astrocytoma tumors, and they also appear in high grade tumors such as GBM.
However, GBM usually appears as a unilateral solid tumor, and a GBM with a cyst is rare [189].
The T1 Gd enhanced MRI scan is used to identify the existence of the cystic component. Figure
2.4 displays axial T1 Gd MRI images for two patients with glioma brain tumors: one with cystic
component and other without cystic components [130]. The cystic region of the tumor appears in
an ovoid shape on the T1 Gd scan (Figure 2.4-A), a well-defined interface, homogeneous hypointensity with an enhanced, even lining on a thin and smooth wall. The non-cystic GBM appears
as an irregular shape on the T1 Gd scan (figure 4.2-B), a poor interface with an enhanced thick
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and uneven wall. Choi et al. reported that the survival rate of glioma patients is better with
presence of cystic components rather than their absents [130]. In sum, existence, size and location
of some GBM sub-regions contribute positively to the survival rate and prognosis outcomes after
diagnosis. Therefore, extracting accurate radiomic information related to the size and location of
GBM sub-regions is essential to train an efficient ML/DL model to predict the patients’ OST.

Table 2.2 Visibility of glioma brain tumor sub-regions on structural MRI scans [30, 173,
177].

Tumor

Structural MRI Scans

Subregion

Whole Tumor

T1

T1 contrast

T2

FLAIR

-

-

-

Bright

-

Less bright

Less bright

Bright region

-

-

Non-enhanced
tumor Core

Enhanced

-

tumor

than T1

Necrosis

Dark

-

Bright

Dark

Edema

-

-

Bright

Bright
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(A)

(B)

Figure 2.4 The axial T1 Gd MRI scans for patients with GBM brain tumor, A) with
cystic component, and B) without cystic components [130].

2.3.3 BraTS 2020 Dataset for Overall Survival Time Prediction System
Appropriate medical datasets that contain meaningful attributes and information with
enough samples are the key to train/validate and test a prediction model for complex tasks, such
as predicting patient’s prognosis outcomes.
This dissertation uses BraTS challenge dataset is used to develop an OST prediction system
for patients with GBM tumors. BraTS 2020 utilized multi-institutional preoperative MRI
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images and focuses on evaluating the state-of-the-art methods to segment glioma brain tumor
subregions since 2012 [30]. The BraTS challenge updates the data every year by adding new
samples, modifying annotations, and adding new information [30, 31, 107] to better diagnose
glioma tumors and increase the understanding of GBM tumor behavior.
The BraTS challenge released segmentation labels for mpMRI scans of the multiinstitutional glioma collections of TCGA including both GBM and LGG collections. These
collections are publicly available in The Cancer Imaging Archive (TCIA) [31]. Table A.3 lists the
source of radiographic data for the GBM and LGG collections in TCIA [31].
The BraTS challenge 2020 released two tasks. The first task is segmentation which focuses
on evaluating the-state-of-the-art segmentation methods to extract the glioma tumor subregions
automatically from MRI images. The second task is the OST prediction which evaluates the stateof-the-art OST prediction methods for patients with GBM tumors. BraTS challenge provides three
datasets: training, validation, and testing. The training dataset is labeled data which are provided
to train and validate a prediction model under supervised learning approach. This data is provided
to develop and evaluate a prediction model in the training phase. The validation and testing datasets
are unlabeled data. The BraTS releases the validation data to allow participants to evaluate the
models they develop in the training phase to choose the best segmentation and/or OST prediction
models. The BraTS released the test data to evaluate the best prediction models for each research
group in the validation phase. Where the evaluation process is performed by the BraTS challenge
in the validation and test phases. Each of the BraTS training, validation, and test datasets contains
segmentation and survival data based on the two BraTS prediction tasks.
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A. BraTS 2020 Segmentation Data
The segmentation dataset consists of preoperative multiparametric structural MRI scans
for glioma brain tumors. The segmentation data is provided to develop and evaluate an automatic
prediction model to segment the three-glioma brain tumor sub-regions, ED, ET, and NCR, as well
as healthy tissues from MRI scans. The segmentation data contains two categories of glioma brain
tumors: LGG and HGG. 293 patients are in the HGG category, and 76 patients in the LGG
category. The BraTS 2020 challenge released three groups of segmentation data: labeled training
dataset which consists of 369 samples (i.e., patients), unlabeled validation dataset, which consists
of 29 samples, and an unlabeled test dataset which consists of 125 samples. As each glioma brain
tumor sub-region is recognized in a specific structure MRI modality, four MRI modalities, T1, T1
Gd, T2, and FLAIR, were provided for each sample of BraTS segmentation data. The training
dataset is labeled data and each sample has a ground truth file (segmentation labels file) for MRI
scans. A segmentation labels file contains four labels as shown in Figure 2.5-A [107]. The first
label has a value of “1” and represents the NCR glioma sub-region. The second label has a value
of “2” and represents the ED glioma sub-region. the third label has a value of “4” and represents
the ET glioma sub-region, whereas the forth label has a value of “0” and represents healthy brain
tissues and the background of the MRI images (BHT/BG). The size of each MRI modality and a
segmentation file is 240 × 240 × (155 slices). The BraTS challenge evaluation measures were
computed on WT, TC, and ET region, as shown in Figure (2.5-B). The WT represents the threebrain tumor sub-regions (NCR+ET+ED), and the TC represents both the two tumor core
components (NCR+ET). Figures 2.6 and 2.7 show MRI modalities and the glioma tumor labels
for two BraTS samples (i.e., patients) with HGG tumors, and Figures 2.8 and 2.9 show MRI
modalities and the glioma tumor labels for two BraTS samples with LGG tumors.
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(A)

(B)

Figure 2.5 Glioma brain tumor regions in a slice from the BraTS dataset [107], A) the three
labels of glioma brain tumor shown in T1 GD scan (image D), B) the brain tumor regions
that were considered in the BraTS evaluation process. Where ET (surrounding the
cystic/necrotic components) is visible in T1 Gd (image A), TC is visible in T2 scan (image
B), and WT is visible in FLAIR (image C).
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HGG

T1

T2

FLAIR

T1 Gd

Labels
(A)

(B)
Figure 2.6 MRI scans and segmentation labels for patient BraTS 100 with an
HGG tumor, A) 2D representation, and B) 3D representation. Labels: Yellow: ED,
Green: ET, Red: NCT, and Blue: healthy tissues and image background.
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HGG

T1

T2

FLAIR

T1 Gd

Labels
(A)

(B)
Figure 2.7 MRI scans and segmentation labels for patient BraTS 224 with an HGG
tumor, A) 2D representation, and B) 3D representation. Labels: Yellow: ED,
Green: ET, Red: NCR/NET, and Blue: healthy tissues and image background.
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LGG

T1

T2

FLAIR

T1 Gd

Labels
(A)

(B)

Figure 2.8 MRI scans and segmentation labels for patient BraTS 327 with an LGG
tumor, A) 2D representation, and B) 3D representation. Labels: Yellow: ED, Green:
ET, Red: NCR/NET, and Blue: healthy tissues and image background.
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LGG

T1

T2

FLAIR

T1 Gd

Labels
(A)

(B)
Figure 2.9 MRI scans and segmentation labels for patient BraTS 334 with an
LGG tumor, A) 2D representation, and B) 3D representation. Labels: Yellow: ED,
Green: ET, Red: NCR/NET, and Blue: healthy tissues and image background.
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B. BraTS 2020 Dataset
The BraTS survival time data contains survival information which includes clinical nonimaging information for patients with GBM brain tumors, such as patients’ age, resection status,
and overall survival time. The BraTS challenge provides patients’ overall survival time as a target
(patients’ outcomes) to be estimated by an automatic prediction model. The BraTS challenge
released three groups of survival data: training labeled survival data which consists of 236 samples
(i.e., patients), validation unlabeled survival data, which consists of 29 samples, and test unlabeled
survival data which consists of 125 samples. The data has three types of resection statuses [107].
Each patient has one of the three types of resection status: gross total resection (GTR), subtotal
resection (STR), and unknown resection status. When 119 patients are with GTR resection status,
and the remains are either with STR or unknown resection status. The BraTS challenge only
evaluates the OST estimations for patients with GTR resection statuses. Table 2.3 displays the
characteristics of BraTS challenge 2020 survival data for patients with a GTR resection status.
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Table 2.3 Characteristics of survival BraTS 2020 dataset with GTR resection status.
SD: standard deviation, Overall Survival Time (OST), Short-term survivors (StSur), Midterm survivors (MdSur), Long-term survivors (LgSur). Notes: the alive sample was
discarded from the computations.
No. Patients (samples)

119

No. Dead patients(samples)

118

No. Alive patients (samples)

1

No. Short-survivor patients (samples)

45

No. Mid-survivor patients (samples)

28

No. Long-survivor patients (samples)

46

Age: Mean (± SD)

61.9 (±12.0255) year

OST: Mean (± SD)

442.6807 (±346.2408) day

Age StSurv: Mean (± SD)

67.1902 (±11.9114) year

Age MdSurv: Mean (± SD)

61.5058 (±10.7946) year

Age LgSurv: Mean (± SD)

57.295 (±11.162) year

OST StSurv: Mean (± SD)

163.3636 (±82.89) day

OST MdSurv: Mean (± SD)

374.3929 (±37.7156) day

OST LgSurv: Mean (± SD)

761.0435 (±346.113) day
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2.4 Preprocessing
The preprocessing step is commonly used before the training process to prepare a suitable
data to train, validate and test a prediction model. Various preprocessing techniques have been
developed and applied to produce efficient prediction models, such as data normalization, data
augmentation, data denoising, and data transformation [190, 191]. These techniques are widely
used to improve the quality of datasets, and increase the size and meaning of datasets, which are
affect the performance of prediction models positively. Data normalization is a process that
transforms all samples in a similar distribution. This process is important not only to speed up
convergence in the training process but also to increase prediction accuracy. The most popular
data normalization methods are mean normalization, min/max normalization, and z-score
normalization [191]. Data augmentation is important preprocessing step that increases the size and
quality of the data as well as to solve overfitting problems. Different techniques have been used as
data augmentation methods, such as scaling, geometric transformation, rotation, cropping, noise
injection, and generative modeling [190]. Moreover, data transformation is an important process
to increase the data size and to extract meaningful information from raw data to train a prediction
model. Features extraction is the most essential data transformation methods that supports training
process [94]. This method is used to extract valuable high-level information from raw data, which
represents low-level information. The importance of this method is clearly proven when
small/medium medical imaging datasets were used to train reliable prediction systems [96, 110]
in medical the field. In addition, feature selection is another data transformation method that is
used for dimensionality reduction and robust features selections [89, 103]. Moreover, data fusions
and feature fusions are commonly used as data transformation in the preprocessing step [89, 190].
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Predictions on healthcare based on supervised learning required a labeling process to
prepare training data that contains strong input attributes with targets. The labeling process is used
as a preprocessing technique to prepare proper datasets for prediction tasks. However, the
healthcare labeling process is expensive, and sometimes cannot take place experts [45]. For
example, experts are required to label each medical image at the pixel level to prepare data for
segmentation task [30, 31]. In fact, this process is a time consuming and expensive. Therefore,
alternative inexpensive and fast methods have been proposed and developed, such as semiautomatic and fully automatic segmentation models based on DL methods.
In this dissertation, we develop novel approaches to extract valuable features from MRI
BraTS scans to train an OST classifier [64, 136-138]. We also used feature fusions, data
normalization, data fusions, and features selection methods as a preprocessing technique to
increase the value of the training data as well as to boost the performance of the prediction systems.
In addition, we use data denoising as a data transformation method in the preprocessing step to
restore the original data information by removing redundant noise information. We also develop a
DL model to automatically label the glioma brain tumor sub-regions in MRI scans. This DL model
enables us to derive valuable high-level information (i.e., radiomic features) from MRI scans based
on shape, size, and location information of the GBM brain tumors to develop OST prediction
system. The features extraction, DL segmentation, and denoising methods are presented in detail
in Chapter Three.

54

2.4.1 Preprocessing Brats 2020 Dataset
Preprocessing is an important step applied by BraTS 2020 challenge to provide wellgeneralized data to develop state-of-the-art methods to segment glioma brain tumor subregions
from MRI scans, and to predict the OST for patients with GMB. The BraTS challenge used a
Computer-Aided labeling procedure to annotate the glioma brain tumor sub-regions in the four
MRI scans, (T1, T2, T1-Gd, and FLAIR) [107]. In this procedure the multi-model DL fusions
approach was utilized as an initial segmentation step to annotate each pixel in MRI scans into one
of the four labels: ED, ET, NCR, and BHT/BG. In this step, high rank DL segmentation models
from previous BraTS challenges were fused together to provide best segmentation labels [30, 31,
107]. Then experts implemented manual revisions on the segmentation results [31, 107]. Finally,
the BraTS challenge involved internationally-recognized neuroradiologists to approve the
segmentation labels. As presented in Tables A.1 and A.2, MRI scans in BraTS data have different
characteristics, and were collected from multiple centers. Therefore, the BraTS challenge applied
data standardization on all MRI scans, such as conversion, re-orientation, co-registration,
resampling, and skull-stripping [31, 107], to generalize the data.
The original MRI scans saved as DICOM files and the BraTS challenge convert it to the
NIFTI file format which is more suitable to save 3D medical imaging data. All the original MRI
scans were re-oriented to a common orientation system, co-registering them to the same
anatomical template. As displayed in Table A.1, the slices thickness for the four MRI modalities
are not equal. Therefore, all MRI scans are resampled to (1 mm3). The preprocessed BraTS data
saved time and efforts that researchers would have spent in the preprocessing step to develop
automatic prediction models. In addition, these BraTS data generalizations allow to compare and
rank researchers’ methods fairly.
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2.5 Modeling
Predictive modeling is a necessary task in the healthcare system to create efficient
estimation models using ML/DL methods and healthcare data. These predictive models are
essential to validate and test the hypotheses and assumptions that are difficult to explain, estimate,
or evaluate accurately by human [192].
There are four types of learning methods that can develop prediction models: supervised
learning, unsupervised learning, semi-supervised learning, and reinforcement learning. The type
of a dataset (labeled or unlabeled), size of a dataset, and type of a task (i.e., prediction,
dimensionality reduction, or features extraction) are the fundamentals to involve a specific learning
method in the predictive modeling process. More details that highlight the differences among these
four learning methods are described briefly below.
i. Supervised Learning
Supervised learning is the learning process that develops a prediction model based on predefined data (labeled data) and it is used widely for classification, segmentation, and regression
tasks. Classification is a process of classifying a given input (a sample from a data) into one of
discrete categories, such as classifying a patient’s medical image into a benign tumor or a
malignant tumor, different types of brain tumors, or different grades of brain tumors (Grade II,
Grade III, and Grade IV) [193]. The Regression models are trained to forecast a continuous
outcome for a given input (i.e., data sample), such as cardiac motion estimation from computed
tomography angiography (CTA) shape information, automatically assessing the pediatric bone age
from hand radiograph using X ray images and forecasting a depression risk based on context using
deep Neural Network (DNN) [194-196] Segmentation is an image classification process but in
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pixel-level. When each pixel in an image is classified into one of a specific class. The segmentation
process is used widely to develop Computer Aided-Diagnosis (CADg) systems based on
radiographic data such as CT, MRI, and X-ray. These models are used as fast, automatic, and
accurate diagnosis methods. They can identify the size, and location of damaged/defect organs in
medical images, such as brain tumors, breast cancers, and lung cancers [28, 48, 58, 65, 80, 84, 87,
99]. In addition, other segmentation models have been developed to perform multi-organ
segmentation, or multi-tissue segmentation task [197].

ii. Unsupervised Learning
Unsupervised learning is a process to generate patterns from unlabeled data. Therefore, this
learning method is exploratory and used to detect undefined patterns and clusters in unlabeled
data. It is commonly used as features selection, data dimensionality reduction, clustering and
classification methods [198-200].

iii. Semi-Supervised Learning
Semi-supervised learning is a learning process based on a small labeled training dataset
and large unlabeled training dataset to develop a prediction model which able to make predictions
on new given input. This learning methods combines both the supervised learning and
unsupervised learning notions. The semi-supervised learning is used to improve the supervised
learning when labeling data is painful and required experts or specific devices [201, 202], for
example semi-supervised framework was proposed to improve the classification results on both
single-label and multi-label disease classification tasks using medical images [203, 204]
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iv. Reinforcement learning
Reinforcement Learning (RL) is a learning method that aims to achieve the optimal
behavior in an interactive environment by using feedback from a series of previous actions. The
RL is similar to supervised learning in mapping between inputs and outputs, but in contrast with
supervised learning as the feedback is a series of correct actions to perform the learning task in the
unsupervised learning approach. Both RL and unsupervised learning perform learning in unlabeled
data. However, they are dissimilar in terms of goals, as unsupervised learning discovers the
similarities and differences between data samples, but RL learns an optimal behavior by achieving
maximum rewards. In general, the availability of medical data is limited and the annotation process
is painful. Thus, RL has been involved as the best ML representation to generate prediction models
[205-207]. For example, Hu et al. developed a prediction model to solve drug infusion problem
for the administration of anesthesia by using the Partially Observable Markov decision process
(POMDP) [205]. In another study, different formulations of reward function in Q-learning were
developed to produce effective drug dosing policies for patient groups with different
characteristics [206]. More recently, Tseng et al. developed an adaptive radiotherapy decision
making method for patients with Non-Small Cell Lung Cancer (NSCLC) based on a multicomponent Deep Reinforcement learning (DRL) [207].
we summarize that deciding a proper learning method is essential to perform an efficient
predictive modeling process. As the BraTS challenge provided a labeled training data, predictive
modeling based on supervised learning approach is used to develop an automatic OST prediction
system for patients with GBM tumors. To avoid overfitting, the labeled data is divided into three
sub-datasets: training, validation, and test datasets. The training dataset is used to train a prediction
model, the validation dataset is used to tune a model’s parameters during the training process, and
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the test dataset is used to test and evaluate the developed prediction models. In general, the size of
a training data is the largest among the three groups of the sub-datasets. The validation data is
known as a development dataset because it is used to tune the parameters of a prediction model
during training process. The validation dataset is essential to eliminate overfitting problems. The
test dataset contains unseen examples (samples) to justify the efficiency of a developed prediction
model toward overfitting problems. Figure 2.10 shows the steps in developing a fully automatic
OST prediction system for GMB patients using the BraTS labeled dataset.
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Figure 2.10 Modeling the automatic OST prediction system for GBM patients.
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2.6 Evaluation and Monitoring
Evaluation and monitoring step evaluates the performance of a developed prediction model
as well as to finalize the modeling process. Test unseen dataset is used to evaluate a developed
prediction model. This step tests the performance of prediction models in terms of bias/variance
problems, and improves the accuracy. Otherwise, the model should be retrained, monitored, and
reviewed to guarantee the expected expectations. To control bias/variance problems, model error
checking must be involved in the modeling step. The procedure to perform the model error
checking process perfectly is shown in Figure 2.11.
High variance occurs when train set error is small compared to a high development set
error. While, the high bias (under fitting) occurs when both training set and development set errors
are high compared to approximately 0% human error. However, the human error is uncertain and
likely to be high when the task is to perform OST predictions for patients with fatal diseases such
as the GBM brain tumor. Thus, low prediction accuracy (55%-70%) is competitive if it is
compared to human error.
Various types of evaluation measures are used to evaluate prediction model performance.
Using the correct measure/ matrices is essential to justify the performance of the prediction model.
The type of a selected evaluation measure depends on the type of prediction task (regression,
classification, or segmentation). AUC, accuracy confusion matrix are common measures and
methods that are used to evaluate classification prediction models. Mean square error (MSE),
absolute error (AE) are commonly used to evaluate regression models.
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Figure 2.11 Model error checking to control bias/ variance.

2.6.1 Evaluations Measures for Overall Survival Time Prediction System
The ML were proposed in this dissertation to develop a prediction model to predict OST
for GBM patients due to the small size of the available survival BraTS 2020 dataset. As mentioned
in the previous Modeling section, the OS prediction system was developed based on ML methods
and meaningful radiomic features that were extracted from MRI scans, as well as clinical
information. Volumetric, shape, and location information were proposed to be extracted from MRI
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scans as radiomic features to train an OST prediction model based on ML techniques to classify
each patient into one of the three classes: short-term survivors, mid-term survivors, and long-term
survivors. To develop a fully automated prediction system for OS based on radiomic features that
involves shape and location information, two prediction models are required: a segmentation
model and multi-classes classification model. The segmentation model segments the glioma brain
tumor sub-regions from mpMRI scans. The volumetric, shape and location features are extracted
from segmentation results by using different strategies and methods which are explained in details
in the chapter three (methods). Therefore, two different groups of measures are used in this
dissertation to evaluate the OST prediction system, and are clarified as follows:
A. Evaluate a Segmentation Model
The common measure to evaluate a segmentation task in medical images is the average dice
similarity coefficient (ADS). The dice similarity coefficient (DSC) is used to calculate the
similarity between a predicted object of interest (P) and its ground truth (GT) in an image, and the
following formula is used to described it:

𝐷𝑆𝐶 =

2 |𝑃. 𝐺𝑇|
|𝑃| + |𝐺𝑇|

2.1

The DSC can be also described in terms of true positive (TP), false positive (FP) and false negative
(FN) as follows:
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𝐷𝑆𝐶 =

2𝑇𝑃
2𝑇𝑃 + 𝐹𝑃 + 𝐹𝑁

2.2

We can calculate ADS for n samples as follows:

𝑛

1
2 |𝑃𝑖 . 𝐺𝑇𝑖 |
𝐴𝐷𝑆 = ∑
|𝑃𝑖 | + |𝐺𝑇𝑖 |
𝑛

2.3

𝑖=1

B. Evaluating Multi-classes Classification Models
The Accuracy (Acc) is one of the most common measures to evaluate a classification
model, and it represents the number of correct predictions over the total number of predictions.
For binary classifier, the ACC can be calculated as follows

𝐴𝑐𝑐 =

𝑇𝑃 + 𝑇𝑁
𝑇𝑃 + 𝑇𝑁 + 𝐹𝑃 + 𝐹𝑁
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2.4

where the TN refers to true negative elements.
In multi-classes classification problem, the confusion matrices are the best way to describe
the prediction performance of each class, along with the system performance. In addition,
a receiver operating characteristic curve (ROC curve) is a plotting measure that provides a visual
description of a classifier performance. In a binary classifier, the ROC curve is used to distinguish
between two different classifiers. The ROC curve can be used as a plotting measure to evaluate a
multi-classes classifier performance by comparing the ROC curves of different classes.
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Chapter 3- Methods

3.1 Introduction
In this chapter, methods to develop the automatic OST prediction system for patients with
GMB brain tumors are presented and explained. The OST prediction system is based on
classification task to categorize a GMB patient into one of the three survival time groups: shortterm, mid-term, and long-term. Patients in the short-term group have the worst OST compared to
other groups at less than 10 months. The survival time for patients of the second group, mid-term
group, is between 10-15 months. While patients in the long-term group have better survival time
than group one and group two, which is more than fifteen months. Deciding a proper prediction
method to train a prediction system depends on the type of the prediction task, and nature and size
of a dataset. As presented in Chapter 2 - Section 2.3.3, the survival BraTS dataset is small in terms
of the number of samples. The OST prediction system is based on multi-classes classification, and
the size of each class (group) is small. For example, there are only 81, 55, and 76 samples (i.e.,
patients) in the short-term, mid-term, and long-term survival time groups in BraTS 2019 training
dataset, respectively. DL methods cannot be used to develop a reliable OST classifier when small
data is available. Therefore, in this dissertation, ML methods have been proposed and presented to
produce an efficient OST prediction system. The BraTS survival data consists of medical imaging
data (preoperative Multimodal MRI scans), and non-clinical imaging data. As presented in
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Chapter Two, the size of a single MRI scan in the BraTS dataset is large as it is a 3D image that
presents volumetric information for the brain region. In addition, the number of samples in each
survival time group is small. Thus, various radiomic features extraction methods are proposed and
developed to train a ML classifier for OST predictions. Radiomic features are meaningful
information in quantitative form that are extracted from medical images. This chapter proposes
and explains five novel features extraction methods to produce an efficient OST calcification
model. These features are: volumetric and location, shape, texture, histogram, and deep features.
To compute radiomic features based on size, shape and location information from MRI images,
radiologists are required to identify and localize GBM brain tumor sub-regions in MRI scans.
Involving experts to extract tumor regions from MRI images is a time consuming and expensive
process. Thus, DL segmentation method has been proposed and presented in this chapter to
segment glioma brain tumor sub-regions automatically from preoperative multimodal MRI scans.
Then, we use the segmentation results to calculate the volumetric, shape and location information
for GBM brain tumors.

3.2 Radiomic Features Extraction Methods
The Feature extraction process is applied in the preprocessing step to extract meaningful
descriptors from MRI scans. We use these descriptors to train a ML classifier to predict the OST
for patients with GBM tumors. In this dissertation, we propose and develop five different feature
extraction methods to develop the prediction system. These methods are volumetric and location
features, shape features, texture features, histogram-based features, and DL features.
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3.2.1 Volumetric and Location Features
We propose and develop this type of feature to describe the size and location information
of a whole brain (WB), WT, ED, ET, NCR, and TC regions from MRI scans. In this dissertation,
two different novel approaches have been proposed and developed to extract volumetric and
location, and are described in detail as follows.
3.2.1.1 Volumetric and Location Features from Whole Brain Volume
The segmentation labels in the BraTS training dataset are used to identify and localize the
GBM tumor sub-regions in MRI scans. These labels are used to compute the volumes of WB, WT,
ED, ET, NCR, and TC regions in an MRI scans by calculating the number of pixels for each 3D
region [64]. We calculated the volumes of NCR, ED, and ET are calculated by counting the number
of pixels that have values labeled 1, 2, and 4, respectively. Thus, we first identified the 𝑋𝑇(𝑘) array
for each brain tumor sub-regions, and then we calculated the volume 𝑉𝑇(𝑘) of each region using
the following formula:

155 240 240

3.1

𝑉𝑇(𝑘) = ∑ ∑ ∑ 𝑋𝑇(𝑘) (𝑖, 𝑗, 𝑧)
𝑧=1 𝑗=1 𝑖=1

where 𝑋𝑇(𝑘) (𝑖, 𝑗, 𝑧)

is a pixel in a specific brain tumor sub-region, and k =

1, 2, and 3 for ED, EN, and NCR tumor region, respectively,
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and 𝑉𝑇(𝑘) ∈ {ED, EN, and NCR tumor volumes for k = 1, 2, and 3, respectively}.
In addition, we calculated the WT volume by counting the pixels that have values more than 0 in
labels segmentation files. To compute the volume of the brain region, we used the OTSU
thresholding method to extract the brain volume from the FLAIR MRI modality.
We used the volumes that are described above to extract size information using the ratio of the
following volumes for each BraTS training sample: {ratio of WT volume to WB volume, ratio of
NCR/NET to WT volume, ratio of ED volume to WT volume, ratio of ET volume to WT volume},
as displayed in Table 3.1 [64].

Table 3.1 Volumetric and location features based on first approach.
Volumetric features
Features

Description

RWT/B

VWB/VWT

RNCR/WT

VNCR/VWT

RED/WT

VED/VWT

RET/WT

VET/VWT
Location features

Features

Description

Distance

Distance between CB and CT

X-direction

(+/-) Right/Left

Y-direction

(+/-) Anterior/ Posterior

Z-direction

(+/-) Superior /Inferior
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To describe the location information of a whole brain tumor, we calculate the distance and
direction between the centroid point of WB and the centroid point of WT for each sample (i.e.,
patient) in the BraTS training dataset. Due to the irregular shape of the GBM brain tumors, we
used the K-means clustering method to calculate the centroids of a brain volume and a WT volume
[64]. We propose and develop the following four features to describe the location information:
{distance, X-direction, Y-direction, and Z-direction}. The distance (d) between two centroid
points in the 3D plane is shown in Figure (3.1), and the following formula is used to calculate it:

|𝑑| = 2√(𝑥1 − 𝑥2)2 + (𝑦1 − 𝑦2)2 + (𝑧1 − 𝑧2)2
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3.2

Figure 3.1 The distance between two centroid points in a 3D plane.

The X-direction describes the location of a centroid of the GBM brain tumor, which could be either
in the left or right part of the brain volume; the Y-direction describes the location of the centroid
of the GBM brain tumor, which could be either in the anterior or posterior part of the brain volume;
while the Z-direction describes the location of a centroid of GBM brain tumor, which could be
either in the superior or inferior part of the brain volume.
These volumetric and location features extraction method resulted in eight volumetric and
location features, as shown in Table 3.1, that were extracted from each a BraTS training sample
to generate features vectors [64]. We then used these vectors to train the OST prediction system.
To extract these features from unlabeled MRI scans, experts must label MRI scans in pixellevel into three glioma tumor sub-regions, as well as a brain healthy region. As involving experts
is an expensive and time-consuming process, we proposed a DL segmentation model to segment
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the glioma brain tumor sub-regions automatically from unlabeled MRI scans [64], as presented in
Chapter Three-Section 3.3.

3.2.1.2 Volumetric and Location Features from Brain Sub-Volumes
The human brain is the most complex and important organs in the human body. The brain is not
only responsible for interacting a human with the environment, but also controls internal human
organs. The brain consists of two halves: right and left. Each half controls the opposite side of the
body. There are four main functional sections in the brain, called lobes. The four lobes in each
half of a brain are: Frontal lobe, Parietal lobe, Occipital lobe, and Temporal lobe. In addition,
there are other sections of the brain, called the Cerebellum and Brain Stem. Each of these
functional sections (regions) are associated with different functions, as shown in Figure 3.2. we
propose extracting the volumes of WT and tumor sub-regions in each brain functional region to
investigate their relation in order to develop a reliable OST prediction system [137]. Based on our
knowledge, there is no automatic software program that can identify the boundaries of each brain
functional region in structural MRI scans accurately. Therefore, a novel method is proposed based
on dividing the brain volume in MRI scans into sub-volumes using the three brain section planes:
mid-Sagittal, mid-Coronal, and mid-Horizontal, as shown in Figure 3.3. We then derived
volumetric features from each brain sub-volume.
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Figure 3.2 Brain functionality regions [208].

Figure 3.3 Brain structural planes [137].
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We propose and develop three different approaches to extract volumetric and location features
using the brain sub-volumes.
i.

The first approach is based on dividing the brain volume into two sub-volumes by using
one of the three brain section planes. Thus, three methods were used to describe the
features of the first approach. The first method is based on using the mid-Sagittal plane to
divide the brain volume into left and right sub-volumes, as shown in Figure 3.4-a; the
second method is based on using the mid-Coronal plane to divide the brain volume into
anterior (front) and posterior (back) sub-volumes, as shown in Figure 3.4-b; the third
method is based on using the mid-Horizontal plane to divide the brain volume into
superior (top) and inferior (bottom) sub-volumes, as shown in Figure 3.4-c. In each of
these three methods, the following five volumetric features are extracted from each brain
sub-volume: volume of a brain region, volume of the WT, volume of ET, volume of
NCR/NET tumor, and volume of ED. In addition, two more volumetric features are
calculated from the whole brain volume to represent the volumes of the brain and WT
tumor regions. The location features are described by the appearance of each tumor subregion in a specific brain sub-volume. Thus, first approach results in twelve volumetric
features for each method, five features from each brain sub-volumes and two features from
the whole brain volume. Tables 3.2, 3.3, and 3.4 display the twelve radiomic features
based on volumetric and location information that are extracted using Sagittal, Coronal,
and Horizontal planes, respectively.
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(A)

(B)

(C)
Figure 3.4 Two brain sub-volumes divided by, A) mid-Sagittal plane, B) mid-Coronal
plane, and C) mid-Horizontal plane [138]
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Table 3.2 Volumetric features extracted from two brain sub-volumes using mid-Sagittal
plane method [138].
Feature Type

Description

Vwb

Volume of the whole brain region

Vwt

Volume of the whole tumor region

VtL

Volume of the whole tumor region in the left volume

VtR

Volume of the whole tumor region in the right volume

VbL

Volume of the brain region in the left volume

VbR

Volume of the brain region in the right volume

VEDL

Volume of the ED tumor region in the left volume

VEDR

Volume of the ED tumor region in the right volume

VETL

Volume of the ET tumor region in the left volume

VETR

Volume of the ET tumor region in the right volume

VNCRL

Volume of the NCR tumor region in the left volume

VNCRR

Volume of the NCR tumor region in the right volume
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Table 3.3 Volumetric features extracted from two brain sub-volumes using mid-Coronal
plane method [138].
Feature Type

Description

Vwb

Volume of the whole brain region

Vwt

Volume of the whole tumor region

VtA

Volume of the whole tumor region in the anterior volume

VtP

Volume of the whole tumor region in the posterior volume

VbA

Volume of the brain region in the anterior volume

VbP

Volume of the brain region in the posterior volume

VEDA

Volume of the ED tumor region in the anterior volume

VEDP

Volume of the ED tumor region in the posterior volume

VETA

Volume of the ET tumor region in the anterior volume

VETP

Volume of the ET tumor region in the posterior volume

VNCRA

Volume of the NCR tumor region in the anterior volume

VNCRP

Volume of the NCR tumor region in the posterior volume
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Table 3.4 Volumetric features extracted from two brain sub-volumes using midHorizontal plane method [138].
Feature Type

Description

Vwb

Volume of the whole brain region

Vwt

Volume of the whole tumor region

VtS

Volume of the whole tumor region in the superior volume

VtI

Volume of the whole tumor region in the inferior volume

VbS

Volume of the brain region in the superior volume

VbI

Volume of the brain region in the inferior volume

VEDS

Volume of the ED tumor region in the superior volume

VEDI

Volume of the ED tumor region in the inferior volume

VETS

Volume of the ET tumor region in the superior volume

VETI

Volume of the ET tumor region in the inferior volume

VNCRS

Volume of the NCR tumor region in the superior volume

VNCRI

Volume of the NCR tumor region in the inferior volume
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ii.

In the second approach, the brain volume is divided into four sub-volumes by crossing the
mid-Sagittal plane and the mid-Coronal (frontal) plane, as shown in Figure 3.5. The four
brain sub-volumes are: anterior-right, anterior-left, posterior-right, and posterior-left. The
same five volumetric features that are described in the first approach are extracted from
each brain sub-volume and two more volumetric from the whole brain volume. Thus, the
second approach results in twenty-two volumetric features.

Figure 3.5 Four brain sub-volumes divided by using the cross of mid-Sagittal and midCoronal planes [137].

iii.

The third approach is based on dividing the brain volume into eight sub-volumes using
the cross of the three brain section planes, as shown in Figure 3.6. The eight brain sub79

volumes are: upper-anterior-right, upper-anterior-left, upper-posterior-right, upperposterior-left, lower-anterior-right, lower-anterior-left, lower-posterior-right, and lowerposterior-left. The number of the volumetric features that are extracted from the third
approach equals forty-two volumetric features, using the same method from the first and
second approaches.

Figure 3.6 Eight brain sub-volumes divided by using the cross of mid-Sagittal, midCoronal, and mid-Horizontal planes [138].
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3.2.2 Shape and Location Features
Shape features play significant role in tumor prediction studies, such as survival time
predictions [65, 67, 94, 108, 112, 114]. The tumor shape features are radiomic attributes extracted
from structural MRI images to describe the size, location, and shape information in 2D and 3D
forms. 2D shape features are extracted based on 2D slices from MRI scans, whereas 3D shape
features represent the 3D information extracted from 3D MRI scans. In this dissertation, the shape
descriptors based on 3D information were proposed to be extracted from MRI scans automatically
to study their ability in predicting the OST for GBM patients based on ML methods. The shape
features are extracted from two tumor regions: whole tumor (ED+ET+NCR) and tumor core
(ET+NCR). To extract shape radiomic features for a brain tumor region from MRI scans,
radiologists must annotate the GBM WT and TC regions in MRI scans accurately. DL
segmentation models can be used as alternative cheap and fast methods to extract these brain tumor
regions, as presented in the next section.
In this method, we propose and extract eight radiomic shape features include location
information from the WT and TC tumor regions, respectively, as listed in Tables 3.5 and 3.6.
These features are: centroid, volume, equivalent dimeter, orientation, principal axis length, surface
area, extent, and solidity.
The centroid represents the center of the mass of a specific tumor region. As each MRI
sample is a 3D image, three features are used to represent the centroid (CX, CY and CZ). The
volume of a specific tumor region feature is calculated by counting the number of pixels in a
specific tumor region. The WT region includes pixels in ET, NCR, and ED regions, while the TC
region includes pixels in ET and NCR regions only. The equivalent diameter represents the
diameter of a sphere that has the same volume of a specific tumor region. The orientation features
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are calculated by using eigen vectors, and they represent the orientation of the ellipsoid that has
the same normalized second central moments as a specific tumor region. As each sample is a 3D
MRI image, three orientation angle features (OX, OY, OZ) are calculated for each specific tumor
region. The principal axis length is a shape feature that represents the length of the major axes of
the ellipsoid with the same normalized second central moments to a specific tumor region. Three
axes length features, AXX, AXY, and AXZ, are extracted from each brain tumor region. The extent
feature represents the ratio of voxels in a specific tumor region to the whole region of the brain
volume. The number of pixels in the TC region divided by the number of pixels in the brain volume
represents the extent of TC, while, the extent of the WT is calculated by dividing the number of
pixels in the WT region by the number of pixels in the brain volume. The surface area feature
represents the area of a specific 3D tumor region. As the GBM tumor has irregular 3D shape, the
surface area is calculated using Crofton formula and run-length encoding [209]. The solidity
feature represents the portion of the smallest convex polygon that contains a specific tumor region.
The number of the shape and location features that are extracted from each tumor region
are eight. Some features required more than a single attribute to represent it such as centroid,
principal axis length, and orientation; each required three attributes to describe its 3D information.
Therefore, the number of the radiomic shape features that are extracted from each brain tumor
region (either WT or TC) is fourteen. As the shape features are extracted from two tumor regions,
WT and TC, twenty-eight radiomic shape features are extracted to create the shape feature vector.
We use this vector to train an automatic OST prediction model for patients with GBM tumors.
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Table 3.5 Fourteen shape features that are extracted from the WT region.
Features

Attribute(s)

Description

CXwt

Centroid in X-dimension for WT region

CYwt

Centroid in Y-dimension for WT region

CZwt

Centroid in Z-dimension for WT region

Volume

Vwt

Volume of WT region

Equivalent

dwt

Diameter of sphere that has same volume of

Centroid

Diameter
Extent

WT region
Ewt

Ratio of voxels in a WT region to the whole
brain region

Orientation

Principal axis

OXwt

Orientation in X-direction for WT region

OYwt

Orientation in Y-direction for WT region

OZwt

Orientation in Z-direction for WT region

AXxwt

Length of major X-axis

AXywt

Length of major Y-axis

AXzwt

Length of major Z-axis

SURwt

Surface area for WT region

length

Surface area
Solidity

Swt

Solidity for WT region
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Table 3.6 Fourteen shape features that are extracted from the TC region.
Features

Attribute(s)

Description

CXtc

Centroid in X-dimension for TC region

CYtc

Centroid in Y-dimension for TC region

CZtc

Centroid in Z-dimension for TC region

Volume

Vtc

Volume of TC region

Equivalent

dtc

Diameter of sphere that has same

Centroid

Diameter
Extent

volume of TC region
Etc

Ratio of voxels in a TC region to the
whole brain region

Orientation

Principal axis

OXtc

Orientation in X-direction for TC region

OYtc

Orientation in Y-direction for TC region

OZtc

Orientation in Z-direction for TC region

AXxtc

Length of major X-axis

AXytc

Length of major Y-axis

AXztc

Length of major Z-axis

SURtc

Surface area for TC region

length

Surface area
Solidity

Stc

Solidity for TC region
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The Matlab function “regionprops3” is used to extract the shape features from the labels of the
BraTS 2020 training dataset and the prediction labels of the BraTS 2020 validation and test
datasets.

3.2.3 Texture Features
The texture of an image refers to spatial arrangements of pixels with different intensities to
recognize similarity and variations in images [64]. Recently, the radiomics community has been
using texture features in the diagnosis process due to the high accuracy achieved by characterizing
variation and complexity of image intensity patterns to identify the intratumorally heterogeneity
[133]. The texture features are extracted either from a specific Region of Interest (ROI) in a
medical image, a whole medical image, or both [59-61, 94, 102]. Due to the high performance
achieved by radiomic statistical texture features based on the gray level co-occurrence matrix
(GLCM), these features often have been used to develop automatic prediction systems [210-213].
The GLCM provides certain information about the spatial distribution of the gray level in the
texture image. However, this information does not describe the shape information. To increase the
meaning and importance of these statistical texture features, Hu et al. extracted texture features of
GLCM from a DWT of Computed Radiography (CR) images to evaluate the recognition rate of
osteosarcoma [214]. They found extracting the texture features from the GLCM of DWT achieved
better classification accuracy than from GLCM only in the osteosarcoma prediction system.
Therefore, in this dissertation, we proposed extracting statistical and intensity features based on
GLCM from DWT of MRI images to develop an OST prediction system for patients with GBM
tumors [64].

85

In general, the DWT provides time and frequency information of a signal. As a signal is
one-dimensional (1D) information, the DWT decomposes it into two types of information: detailed
information from a high-pass filter, and approximation information from a low-pass filter. 2D
DWT composes an image, which is a 2D information, into four components: approximation (cA),
horizontal (cH), vertical (cV), and diagonal (cD), as shown in Figure 3.7-A. The cA is the most
important component of DWT from a low-pass filter which provides an accurate and reduced
version of an image. Therefore, the GLCM information was computed from the cA component to
extract statistical texture features. Figure 3.7-B shows db4 – level2 DWT decomposition of an
MRI slice from FLAIR modality of the BraTS 2017 training dataset.
The FLAIR MRI modality is identified as the best MRI scan at displaying the WT region
clearly compared to other MRI modalities such as T1, T1 GD, and T2 [30, 173, 177]. Thus, we
propose extracting texture features from each MRI FLAIR modality to develop the OST prediction
system. We extracted two types of texture information from each slice of the FLAIR modality:
four statistical texture features, and nine intensity texture features [64], as shown in Table 3.7. This
resulted in a total of 2,015 (13 texture features × 155 slices) texture features for each sample (i.e.,
patient) in the BraTS training dataset. Then we use these radiomic features to train an automatic
OST classification model based on ML methods for patients with GBM brain tumors. We clarify
the type texture features that we propose and extract in this dissertation as follows.
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Lo_D

Lo_D

2↓

cAj+1

Hi_D

2↓

cHj+1

Lo_D

2↓

cVj+1

Hi_D

2↓

cDj+1

2↓

cAj

Hi_D

2↓

(a)

2D medical image

Two-levels DWT

Components of the two-levels 2D DWT

(b)

Figure 3.7 2D Discrete Wavelet Transform decomposition for 2D information
(image data), (a) one level Image decomposition, (b) 2-level decomposition of a
FLAIR MRI slice.
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Table 3.7 Thirteen radiomic texture features from each slice of a FLAIR MRI scan.
Texture Features

Type

Extracted from

Statistical Texture

GLCM

Contrast (𝐶𝑜𝑛𝑡)
Correlation (𝐶𝑜𝑟𝑟)

Features

Homogeneity (𝐻𝑜𝑚𝑔)
Energy (𝐸𝑛𝑔𝑦)
Mean (𝑀)
Standard Deviation (𝑆𝐷)
Variance (𝑉𝑎𝑟)
Skewness (𝑆𝑘 )

Intensity Texture

Kurtosis (𝐾𝑢𝑟𝑡)

Features

Entropy (𝐸𝑛)
Smoothness (𝑆𝑚)
Inverse Difference Moment (𝐼𝐷𝑀)
Root Mean Square (𝑅𝑀𝑆)
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DWT

3.2.3.1 Statistical Texture Features
We apply the DWT to the FLAIR MRI modality to obtain the cA component. We then
extract the GLCM from the cA component, as shown in Figure 3.8. The following four statistical
texture features are derived from the GLCM:
i.

Contrast defines the intensity contrast between a pixel and its neighbor over the whole
MRI slice.

𝑪𝒐𝒏𝒕𝒓𝒂𝒔𝒕 = ∑𝒊 ∑𝒋(𝒊 − 𝒋)𝟐 𝑵𝒅 (𝒊, 𝒋)

3.3

where 𝑁𝑑 (𝑖, 𝑗) represents the GLCM data of an image at location (𝑖, 𝑗).

ii.

Correlation defines the spatial dependencies between a pixel and its neighbor in an image:

𝑪𝒐𝒓𝒓𝒆𝒍𝒂𝒕𝒊𝒐𝒏 = ∑𝒊 ∑𝒋

(𝒊−𝝁𝒊 )(𝒋−𝝁𝒋 )𝑵𝒅 (𝒊,𝒋)
𝝈𝒊 𝝈𝒋
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3.4

where 𝜇𝑖 , 𝜇𝑗 𝑎𝑛𝑑 𝜎𝑖 , 𝜎𝑗 are the horizontal and vertical means and variances.

iii.

Homogeneity defines the closeness of the distribution of elements in the GLCM
information to the GLCM diagonal:

𝑯𝒐𝒎𝒐𝒈𝒆𝒏𝒆𝒊𝒕𝒚 = ∑ ∑
𝒊

iv.

𝒋

𝑵𝒅 (𝒊, 𝒋)
𝟏 + |𝒊 − 𝒋|

3.5

Energy measures the similarity or uniformity of an image, and it is defined as angular
second moment as follows:

𝑬𝒏𝒆𝒓𝒈𝒚 = ∑ ∑ 𝑵𝟐𝒅 (𝒊, 𝒋)
𝒊

𝒋
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3.6

3.2.3.2 Intensity Texture Features
Nine intensity texture features are extracted from db4-level3 DWT of a FLAIR MRI scan,
presented in Figure 3.8. These features are defined as:
i.

Mean (𝑴) is the sum of the intensity values of pixels divided by the number of pixels in
an MRI slice, and it is calculated as follows:

𝒎−𝟏 𝒏−𝟏

𝟏
𝑴=
∑ ∑ 𝒇(𝒊, 𝒋)
𝒎∗𝒏

3.7

𝒊=𝟎 𝒋=𝟎

where 𝑓 represents the cA3 component of a FLAIR slice size (m=240, n=240) pixels, and 𝑓(𝑖, 𝑗)is
the value of a pixel at location (𝑖, 𝑗).

ii.

Standard Deviation (𝑺𝑫) defines the spread of the gray level around the mean. It is the
second central moment that describes probability distribution of an image:
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𝒎−𝟏 𝒏−𝟏

𝟏
𝑺𝑫 = √
∑ ∑(𝒇(𝒊, 𝒋) − 𝑴)𝟐
𝒎∗𝒏

3.8

𝒊=𝟎 𝒋=𝟎

iii.

Variance (𝑽𝒂𝒓) is the square root of standard deviation:

𝑽𝒂𝒓 = √𝑺𝑫

iv.

3.9

Skewness (𝑺𝒌 ) is the measure of symmetry of the intensity distribution in an image. The
skewness of a random variable 𝑋 is denoted as 𝑆𝑘 (𝑋), and is defined as:

∑(𝒇(𝒊, 𝒋) − 𝑴)𝟑
𝟏
𝑺𝒌 (𝑿) = (
)
𝒎∗𝒏
𝑺𝑫𝟑
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3.10

v.

Kurtosis (𝑲𝒖𝒓𝒕) is a measure of peakedness or flatness of the intensity distribution. The
kurtosis is calculated as the fourth central moment. For the random variable 𝑋, the Kurtosis
is denoted as 𝐾𝑢𝑟𝑡 (𝑋, )and is defined as:

𝑲𝒖𝒓𝒕 (𝑿) = (

vi.

∑(𝒇(𝒊, 𝒋) − 𝑴)𝟒
𝟏
)
𝒎∗𝒏
𝑺𝑫𝟒

3.11

Entropy represents the amount of randomness in gray level intensity distribution of an
image:

𝑬𝒏𝒕𝒓𝒐𝒑𝒚 = − ∑ ∑ 𝒇(𝒊, 𝒋)𝒍𝒐𝒈𝟐 𝒇(𝒊, 𝒋)
𝒊

vii.

3.12

𝒋

Smoothness is a measure of gray level contrast that can be used to establish descriptors of
relative smoothness:
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𝑺𝒎𝒐𝒐𝒕𝒉𝒏𝒆𝒔𝒔 = 𝟏 −

viii.

3.13

Inverse Difference Moment (IDM) is expressed as:

𝑰𝑫𝑴 = ∑ ∑
𝒊

ix.

𝟏
𝟏 + 𝑺𝑫

𝒋

𝒇 (𝒊, 𝒋)
𝟏 + |𝒊 − 𝒋|

3.14

Root Mean Square (RMS) is expressed as:

∑𝒎
𝒊=𝟏|𝒇𝒊.𝒋 |
√
𝑹𝑴𝑺 =
𝒎

𝟐
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3.15

Figure 3.8 Steps to extract statistical and intensity texture features from the FLAIR
MRI modality.
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3.2.4 Histogram-based Features
A histogram is a graphical representation that organizes a group of pixels’ intensities
(values) into a specific range. The color variations in MRI images distinguish between different
tissues and organs [178, 179], which is important to identify abnormalities. For example, fat
appears as a white color, and white matter as black in the FLAIR modality. While Gray Matter,
and ED appear as variations of bright gray in the FLAIR modality [178, 179]. We propose a simple
features extraction method based on the histogram distribution of brain volume in MRI images to
develop the OST prediction system [64]. In general, MRI images consist of two types of
information: image background and image foreground. The image foreground contains the data of
an organ, for example, the brain. The image background does not contain any organ information
aside from the background pixels that are added to the MRI data to generate MRI images. The size
of the MRI image background is large and consists of only black pixels compared to the foreground
information such as a brain. This means the number of the black pixels that represent the MRI
image background is huge compared to other pixels that represent an organ (foreground
information). To reduce the influence of the background pixels, we use the OTSU thresholding
method to extract the foreground information (brain region) as the ROI. We then extract the
histogram features from the ROI for each sample of the BraTS dataset. The FLAIR MRI modality
is the best structural MRI modality that can display the WT region. Therefore, we use the FLAIR
modality to extract the histogram features. Figure 3.9 shows the steps to extract the histogram
distribution of six samples from the BraTS dataset. The histogram distribution is used to train an
OST prediction model based on ML methods for patients with GBM tumors.
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OTSU

Histogram

Figure 3.9 Steps to extract histogram distribution for samples 67- 72 from the
BraTS 2018 dataset.
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3.2.5 Deep Learning Features
Most of the developed research ideas based on DL focus on using big data and an efficient
DNN structure to develop numerous of meaningful features from data during training process to
produce an accurate prediction model [215-219]. Due to the high performance of DL structures,
other research ideas focus on using pre-trained DL models based on transfer learning technique to
generate accurate prediction models. The main idea of transfer learning is to reduce the need for
big labeled datasets to develop efficient prediction models [220]. Therefore, the transfer learning
has been used widely in various medical images classification tasks when availability of big
medical images data is limited [220-222]. In general, there are many advantages over using transfer
learning technique instead of building new DL model, such as decreasing number of computations,
speeding up a training process (fast convergence) [221, 222], extracting meaningful DL features
[58, 62, 64, 89], developing accurate DL models even with medium/small size data [219, 222],
and easily modifying the architecture of pre-trained DL models for new tasks [220, 222].
Two different methods have been used to benefit from pre-trained DL models: fine-tuning,
and features extraction. In the fine-tuning method, the whole or part of a pre-trained DL model is
used to develop a prediction model for new or different task even with small data size [220].
However, it can be hard to fine-tune a pre-trained DL model with very small medical images
datasets. Thus, researchers used pre-trained DL models as a feature extraction method in
medium/small medical images datasets [62, 64, 89]. The extracted DL features from the pretrained DL model are used to train efficient prediction models based on traditional ML methods,
such as SVM, KNN, R, etc. [62, 64, 89].
This dissertation uses the pre-trained AlexNet to extract 2D global and local DL features
from the ROI (the brain tumor region) in MRI images. AlexNet is a Convolutional Neural Network
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(CNN) classification model that was developed based on 2D DL structure to classify a colored
image into one of 1000 classes. We use this model as a feature extraction method due to its high
performance in the ILSVRC-2012 competition, achieving top-5 on the test classification error rate
[219]. The structure of this model was designed to process image size 227×227×3. This model
consists of three types of DL layers: Convolutional layer (Conv), Max-Pooling layer (Maxpool),
and a Fully-Connected layer (FC). It has a total of eight layers [219]; layer 1 - layer 5 are Conv
layers, and the last three layers are FL layers; the Conv layers are used to develop global and local
features from the data during the training process. the Maxpool layer is used after three of the Conv
layers to reduce the size of the features map, as shown in Figure 3.10. The FC layers are in the end
part of the network, and they are only feed-forward layers. These layers were used to develop
meaningful high-level features to describe the classification task accurately. The last FC layer is
the output layer, and the SoftMax activation function is used instead of ReLU to classify an image
into one of 1000 classes.
For DL features extraction based on the pre-trained DL model, we extract the first seven
layers from the pre-trained AlexNet model excluding the last FC layer (output layer) which was
used to perform the classification process. AlexNet has a 2D DL architecture that is able to process
2D colored images by using three input channels. A single MRI modality cannot be fed directly to
the network as it is a 3D image, thus we use a single slice from an MRI scan. To extract DL
features, we use two steps: ROI preparation, and feature extraction. In the ROI preparation step,
we use the labels segmentation files from the BraTS training dataset to identify and crop the brain
tumor region only from a single MRI slice to prepare valuable 2D input patches. We used the
patches that contains the three-brain tumor sub-regions. As each of the three MRI modalities, T1,
T2, and FLAIR, visualizes a specific glioma brain tumor sub-region, a corresponding slice from
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each of these modalities are used as an input to one of the network three input channels [64]. We
resized each of the input patches to the size of the pretrained AlexNet input layer (227×227). In
the second step, the features extraction step, we used the first seven layers to extract the 1024 DL
radiomic features. We proposed using these features to train the OST prediction system for patients
with GBM tumors based on a multi-classes classification task, as shown in Figure 3.11.

Figure 3.10 Architecture of the AlexNet.
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Preprocessing

T2

T1 Gd

FLAIR

Figure 3.11 Steps to develop an OST prediction system for patients with GBM tumors
based on radiomic DL features using AlexNet.
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3.3 Modified 3D U-Net Segmentation Model for Glioma Tumor Sub-regions
As the size of the BraTS 2020 dataset is small, we propose using ML methods with robust
radiomic features to develop an automatic OST prediction system based on multimodal MRI data
and clinical non-imaging data. Extracting radiomic features of the glioma brain tumor based on
size and location information from MRI data require radiologists to annotate accurately the brain
tumor sub-regions in MRI scans. However, using experts to annotate glioma brain tumor subregions in unlabeled MRI data is an expensive process. Therefore, we proposed developing a DL
segmentation model as an alternative segmentation method to segment glioma brain tumor subregions automatically from MRI scans. Segmentation models are developed to perform a
classification task in the pixel-level instead of the image-level. These models have been used
widely to improve medical diagnosis by performing automatic segmentations on medical images
to detect size and location of abnormalities [223, 227].
Based on the top achievements in the BraTS 2017-2019 segmentation task, most highperformance DL segmentation models were developed based on modified U-Net architecture [12,
116, 119-121, 124, 125], as listed in Table 1.3. The original U-Net DL model was proposed by
Ronneberger et al. to perform accurate segmentations in a2D small medical imaging data [85].
Although, the 2D U-Net architecture was modified and used to perform accurate various
segmentation tasks in 3D medical data, 3D U-Net performed better than 2D U-Net in 3D medical
data [225, 226]; this is due to ability of the 3D U-Net to learn the spatial information in the 2D
patches (slice) as well as inter-slice relationship that describes the depth information in 3D medical
patches by using 3D kernels instead of 2D kernels [227]. For example, 3D kernel size (H×W×D)
can analyze a 3D patch size (H×W×D), and 2D kernel size (H×W) can analyze a 2D patch size
(H×W), where the H, W, and D refer to the high, width and depth information, respectively. Thus,
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due to availability of efficient GPUs that can handle a large amount of complex computations, the
3D U-Net architectures were developed to not only improve the segmentation performance but
also to speed up learning convergence and reduce the training time [225, 227]. Therefore, this
dissertation proposes and develops a modified 3D U-Net as an automatic labeling system to extract
the glioma brain tumor sub-regions from MRI scans.
In general, the architecture of segmentation CNN models consists of two stages: Encoder
and Decoder [227, 228]. The Encoder stage is a contracting path that consists of encoder blocks.
This path is used to derive accurate low-level features from data during the training process. The
encoder part reduces the size of an input patch but increases the number of the kernels; these
kernels are used to develop various type of meaningful low-level features. In each encoder block,
the Conv layers are used to increase the number of meaningful deep low-level features while a
MaxPool layer is used to reduce the size of the input patches. The decoder stage is expanding path
which consists of decoder blocks. This path is used to develop high-level features to provide
accurate spatial information of each pixel in images. In fact, the decoder part is very important to
restore original patch size and develop spatial descriptors by using the up-sampling process.
Usually, the deconvolutional layers (DeConv) are used to perform the up-sampling process in the
decoder blocks. The main improvement of the U-Net over the CNN segmentation models based
on DL encoder/decoder architecture, adds concatenation paths between the encoder stage and
decoder stage to retrieve the spatial information lost in the down-sampling process [229]. The
concatenation paths are used as skip connections to connect the low-level features before the downsampling process in an encoder block with the high-level features in the corresponding decoder
block. These concatenated features contribute in increasing the meaning of high-level features to
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produce better spatial information for each pixel in an image, and speeding-up model convergence
even when small medical imaging datasets are used to develop segmentation models.
In this dissertation, we propose two segmentation models based on modified 3D U-Net
architecture. Both these models are designed to process 3D input patches which contain volumetric
imaging information. As different MRI modalities are used to recognize each glioma brain tumor
sub-regions [30, 31, 107], the input layer of the DL segmentation model consists of four channels
to consider the four MRI modalities in the BraTS datasets (T1, T1 Gd, T2, and FLAIR). Each
channel is used to extract meaningful descriptors from a specific MRI modality to describe a
specific glioma sub-region. As the developed U-Net models are based on 3D DL network, we
crop input patches size 64×64×64 from each MRI modality in the BraTS dataset. To overcome
unbalanced data problems and avoid overfitting each cropped patch is selected based on
availability of all classes. We also use the patch normalization process in each input channel to
make all the patches in the same distribution. The two proposed architectures of 3D modified UNet models are described as follows [137].

3.3.1 3D Modified U-Net
The modified 3D U-Net is developed based on three levels of Encoder/Decoder units which
are connected by concatenation paths [137], as shown in Figure 3.12-a. The encoder part consists
of three encoder blocks to perform the contracting path. Each Encoder block consists of two Conv
layers and one MaxPool layer. The batch normalization technique was developed to solve the
Internal Covariate Shift (ISC) problem which occurs due to the change in parameters of a DL
network during training process [230]. This technique allows to increase the learning rate and
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reduce the importance of learning rate initialization. In addition, it eliminates use of the dropout
process which was proposed to reduce the overfitting problem and to improve generalization errors
[231]. Thus, each Conv layer is followed by a Batch Normalization layer (BN) and a non-linear
activation function “Rectifier Linear Unit (ReLU). In each encoder block, the number of filters is
doubled in the second convolutional layer. Whereas, the decoder part consists of three decoder
blocks to perform the expanding path which is used to restore the original size of an input patch
with decreasing the size of features map. Each decoder block consists of two Conv layers, and one
DeConv which is used to perform the up-sampling process. Each Conv layer in a decoder block is
followed by the BN layer and ReLU. The depth-wise concatenation is applied in the beginning of
each decoder block to connect the low-level features with high-level ones. As the BraTS
segmentation data is highly unbalanced data, we used Generalized Dice Loss (GDL) to perform a
multi-class segmentation task. The following formula is used to calculate the GDL:

𝐺𝐷𝐿 = 1 −

𝑀
2 ∑𝐾
𝑘=1 𝑤𝑘 ∑𝑚=1 𝐺𝑇𝑘𝑚 𝑃𝑟𝑘𝑚
𝑀
2
2
∑𝐾
𝑘=1 𝑤𝑘 ∑𝑚=1 𝐺𝑇𝑘𝑚 + 𝑃𝑟𝑘𝑚

3.16

when the “GT”, and “PR” refer to the ground truth image, and prediction image, respectively. The
variable K represents the number of the classes, and variable M defines the number of elements in
the 3D image. The variable “wk” refers to a specific class weighting factor which is used to reverse
the influence of larger classes and improve learning of smaller classes.
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3.3.2 3D Modified U-Net based on Accumulated Encoder (U-NetAE)
The second model is very similar to the first model but only includes Accumulated Encoder
block instead of a regular encoder block in the contracting path [137]. We propose and develop a
novel 3D U-Net model based on the Accumulated Encoder block (AE). This block is designed to
improve the quality of the low-level features by combining two different feature maps by using an
elements-wise addition. To develop these new features, we use two branches after the MaxPool
layer in each encoder block. Each branch has a different kernel size: the first branch increases the
features map by using a Conv layer (kernel size 1, stride= 1, padding= same), while the second
branch increases the features map by using convolutional layer (filter size 3, stride = 1, padding =
same), as shown in Figure 3.12-b. We use the MaxPool layer after the element-wise addition layer
in each encoder block. Thus, the concatenated features in each decoder block contain new lowlevel features from the corresponding encoder block.
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(a) 3D U-Net with regular encoder

(b) Accumulated Encoder
Figure 3.12 Architecture of the modified 3D U-Net, a) based on three levels of Encoder/Decoder
blocks, and (b) based on Accumulated Encode block [137].
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3.4 Methods to Improve the Performance of the OST Prediction System
To improve the performance of prediction models, we propose and develop various preprocessing
and postprocessing methods, such as data analysis and processing methods, postprocessing filters,
and information fusions. Data analysis and processing methods are employed to improve the
quality and size of training datasets, including data denoising, data augmentation, data
normalization, data transformation, synthesis data generation, and information fusions. In this
dissertation, preprocessing and postprocessing methods are proposed and developed to improve
the quality and meaning of the BraTS training dataset as well as to increase the prediction accuracy
of the OST prediction system for parents with GBM tumors. Figure 3.13 displays preprocessing
and postprocessing methods that are developed in this dissertation. For preprocessing stage, we
used image denoising, data augmentation and normalization, data transformations, and data
fusions. Three information fusions methods are used in this dissertation: data fusions, feature
fusions, and model fusions. The data fusions are used to increase the meaning of the training data
by combining two different types of medical data to develop the OST prediction system: medical
imaging data, and clinical non-imaging data. In addition, different types of feature fusion methods
are used to improve the quality of the training descriptors as well as to boost the system accuracy.
For the postprocessing stage, we use ensemble models based on decision fusions to improve
prediction results. Moreover, we studied the type of noise in the BraTS MRI images, and
investigated the effect of the noise on the OST prediction system based on histogram features.
More details about the noise in MRI images and the denoising process are explained below.
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Pre-Processing Step
1. Data Fusion
Medical Imaging Data

Clinical Non-imaging Data

Imaging data
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• Age (Year)
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Denoising
Wavelet

DL segmentation
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Radiomic Feature
Extraction3
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Extraction2

➢ Size and Location
➢ Shape

➢ Texture
➢ Deep Learning

➢ Histogram

Clinical Feature
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2. Feature Fusions
Feature vector1
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Feature vector2

Modeling
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Model2
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𝒏𝒌

∑ 𝑴𝒐𝒅𝒆𝒍𝒍
𝒍

Ensemble Model M

Figure 3.13 Steps to improve performance of OST prediction system.
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3.4.1 Noise in MRI Images
The histogram distributions of the BraTS MRI images show that MRI images have same
distribution, as shown in Figure 3.9. The MRI machine corrupted the raw MRI data with noise
[134, 135]. There are two types of MRI machines based on the number of coils: single-coil
machines, and multi-coil machines. Single-coil MRI machines produce MRI singles corrupted
with Rician noise [134]. While the multi-coil (parallel) MRI machines produce MRI signals
corrupted with non-central chi-distribution [135]. These types of noise make random fluctuation
in the MRI image, which prevent a nonzero mean and cause bias to MRI data when the SNR is
low [232].
Four phases are used in MRI machines to create MRI images: data collection phase,
preprocessing phase, reconstruction phase, and post-processing phase [233]. In the data collection
phase, the raw MRI data, K-space, is collected from the radiofrequency coil(s) in analog form. The
analog data is converted to the digital form in the preprocessing phase, so it can be processed by a
digital computer. Then, the processed MRI data is converted into a visual meaningful image in the
reconstruction phase. The final phase is the postprocessing phase, which is used to remove the
noise from the reconstructed MRI image. The raw frequency-domain measurements, k-space (𝐷),
of the raw MRI data consists of real data (𝐷𝑅𝑒 ) and imaginary data (𝐷𝐼𝑚 ) as presented in the
following formulas:

𝐷(𝑥, 𝑦) = 𝐷𝑅𝑒 (𝑥𝑓 , 𝑦𝑓 ) + 𝑖 𝐷𝐼𝑚 (𝑥𝑓 , 𝑦𝑓 )
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3.17

where 𝐷𝑅𝑒 represents the real component in the (𝑥𝑓 , 𝑦𝑓 ) frequency domain, and 𝐷𝐼𝑚 represents the
imaginary component in the (𝑥𝑓 , 𝑦𝑓 ) frequency domain. Applying the Inverse Discrete Fourier
Transform (IDFT) on the raw MRI data resulted in two components 𝑅𝑒𝑎𝑙 and 𝐼𝑚𝑎𝑔𝑖𝑛𝑎𝑟𝑦, which
is described as follows:

𝑑(𝑥, 𝑦) = 𝑅𝑒𝑎𝑙 + 𝑖 𝐼𝑚𝑎𝑔𝑖𝑛𝑎𝑟𝑦

3.18

The two components are described as follows:

𝑅𝑒𝑎𝑙 = 𝑠(𝑥, 𝑦) cos(𝜃(𝑥, 𝑦)) + 𝑛𝑅𝑒 (𝑥, 𝑦)
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3.19

𝐼𝑚𝑎𝑔𝑖𝑛𝑎𝑟𝑦 = 𝑠(𝑥, 𝑦) sin(𝜃(𝑥, 𝑦)) + 𝑛𝐼𝑚 (𝑥, 𝑦)

3.20

Where the MRI signal is denoted as 𝑠(𝑥, 𝑦), and 𝑛𝑅𝑒 (𝑥, 𝑦) and 𝑛𝐼𝑚 (𝑥, 𝑦) represent the zero
mean White Gaussian Noise (WGN) in real and imaginary components, respectively. The MRI
machine produces MRI images which are calculated as the magnitude value of 𝑑(𝑥, 𝑦) , as
presented below:

2

|𝑑(𝑥, 𝑦)| = √(𝑅𝑒𝑎𝑙)2 + (𝐼𝑚𝑎𝑔𝑖𝑛𝑎𝑟𝑦)2

3.21

Thus, the distribution of the noise in MRI images is not additive noise (WGN) but either Rician
distribution or non-central Chi-distribution depending on the number of coils of an MRI scanner.

3.4.2 Denoising MRI Images using Wavelet Transform
A wavelet system consists of a set of building blocks to construct information (signal or function)
[234]. A wavelet transform is used as a denoising method to recover original information in data
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[234]. The Daubechies family of wavelets (dbN) are asymmetric wavelets [235], and have a set of
scaling functions that are orthogonal [236], where N is the number of zero moments. The following
formula describes the mother function of the Daubechies family [237]:

2𝑁−1

𝜓(𝑥) = √2 ∑ (−1)𝑘 ℎ2𝑁−1−𝑘 𝜑(2𝑥 − 𝑘)
3.22

𝑘=0

where ℎ0 , … , ℎ2𝑁−1 are the filter coefficients and the father, or the scaling function [237].

2𝑁−1

𝜑(𝑥) = √2 ∑ ℎ𝑘 𝜑(2𝑥 − 𝑘)
3.23

𝑘=0

To denoise a noisy image, three sequential steps are used: decomposition, thresholding,
and reconstruction. The first step of the denoising process is known as decomposition discrete
wavelet transform. The decomposition step is characterized by the wavelet transformation of a
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noisy signal with true signal and noise components, respectively. An estimator for wavelet
coefficients is then implemented in an orthonormal basis as follows [238]:

𝐵 = {𝑔𝑚 }0≤𝑚<𝑁

3.24

Subsequently, it is used in conjunction with a thresholding function 𝜌. This process is described
by:

𝑁−1

𝑋̂ = ∑ 𝑃𝑚 (𝑋)({𝑋, 𝑔𝑚 })𝑔𝑚
3.25

𝑚=0

The aim of this transformation is to reduce noise components while maintaining the true
signal coefficients [238]. As the image is 2D information, it runs through two type of filters, lowpass (Lp) and high-pass (Hp)filters, in the decomposition analysis [238], as shown in Figure 3.14.
The low pass filter represents the scaling function, and the high pass filter represents the chosen
wavelet function. In this step, an image is decomposed into four sub-bands, one of the
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approximation coefficients, and three of the wavelet image coefficients. These sub-bands are:
Low-Low (LL), Low-High (LH), High-Low (HL), and High-High (HH). The LL sub-band is the
approximation coefficients which represents all the coefficients filtered by the two Lp analyses
ending with the coarse coefficients of the original image. HL sub-band information represents the
horizontal edges of the image, and the LH sub-band information represents the vertical edges. HH
sub-band information represents the diagonal edges of the image. An N level wavelet
decomposition process produces 3N + 1 different sub-bands [239], for example, two-level wavelet
decomposition for 2D information (image) results in seven sub-bands as shown in Figure 3.15.
The second step in the wavelet denoising analysis is wavelet thresholding. Wavelet
thresholding is a non-linear method that uses a single wavelet coefficient at a time to compare it
against the selected threshold. The coefficient is set to zero if it is smaller than the selected
threshold; otherwise, it remains the same. Setting zero for the noisy coefficients allows to restore
image original information in the in the Inverse wavelet reconstruction step. There are two
thresholding methods can be used, hard-thresholding and soft-thresholding, as shown in Figure
3.16. The soft and hard thresholding are described as follows, respectively:

𝜌𝑇 (𝑥) = {

𝑥 − 𝑇,
𝑥 + 𝑇,
0,

𝑖𝑓 𝑥 ≥ 𝑇
𝑖𝑓 𝑥 ≤ −𝑇
𝑖𝑓 |𝑥| < 𝑇

3.26
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𝑥,
𝜌𝑇 (𝑥) = {
0,

𝑖𝑓 |𝑥| > 𝑇
𝑖𝑓 |𝑥| ≤ 𝑇

3.27

where 𝑥 and 𝑇 represent the magnitude of the wavelet coefficients and the threshold, respectively
[240].
We use the soft-thresholding method, and we calculate the thresholding value by using universal
or global thresholding value [240].

Figure 3.14 2D Wavelet decomposition analysis. When Lo_D represents low-pass
decomposition, and Hi_D represents the High-pass decomposition.
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Figure 3.15 Two-Level Wavelet Decomposition sub-bands.

(a)

(b)

Figure 3.16 Thresholding methods, a) Hard thresholding, and b) Soft-thresholding [240].
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The third step is called wavelet reconstruction synthesis which uses up-sampling and filtering to
reconstruct the image’s original information. This step allows the user to denoise an image by
restoring the image original information. Usually, Mean Square Error (MSE) and Signal-to-Noise
Ratio (SNR) are used as quantitative measures to evaluate the denoising process. However, the
raw clean MRI data are not available to evaluate the wavelet denoising process. Thus, we use the
denoised information to train the OST classifier, and we decided to compare the accuracy of
denoised data with the accuracy of noisy data to evaluate the denoising process.
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Chapter 4- Experimental Results and Performance Evaluations

4.1 Introduction
In this chapter, various experiments were conducted based on various radiomic features
(presented in Chapter Three), such as volumetric, location, shape, texture, histogram and deep
learning features, and ML methods to develop an efficient OST prediction system for GBM
patients based on classification task. The prediction system was developed to classify a GBM
patient into one of the three survival time groups: Short-term (< 10 months), mid-term (10-15
months), and long-term (> 15 months). Three versions of the BraTS challenge datasets were used
to develop, evaluate and test the performance of the OST prediction system: BraTS 2017, BraTS
2019, and BraTS 2020. Two types of data, imaging and non-imaging, were used to develop the
OST prediction system. To improve the performance of the developed OST prediction system,
preprocessing and postprocessing methods, such as feature fusions, ensemble models and
denoising process, were involved. In addition, a 3D DL segmentation model based on modified
U-Net structure was developed by using mpMRI scans and segmentation labels files to extract the
three glioma brain tumor sub-regions automatically: NCR, ET, and ED. This DL model was used
as an alternative, inexpensive and fast method instead of involving radiologists to localize and
recognize the glioma brain tumor sub-regions in MRI scans. Then segmentation results were used
to extract automatically the size, location and shape information (features) of the GBM tumor from
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MRI modalities. Table 4.1 displays the characteristics of the BraTS training dataset that were used
in these experiments. The BraTS challenge increased/modified the size and information of the
BraTS data each year. The size of the survival BraTS training dataset is 163, 212, and 236 in the
BraTS 2017, BraTS 2019, and BraTS 2020, respectively. In addition, the BraTS challenge
improved and added more information related to the prognosis outcomes of GBM patients each
year. For example, the survival BraTS 2017 dataset contains patients’ age and overall survival
time as clinical non-imaging information. The BraTS 2019 and BraTS 2020 included the resection
status information in addition to the age and survival time for the GBM patients. Three types of
resection status were provided: GTR, STR, and unknown. The experiments and results were
presented and explained based on three groups of the BraTS datasets: BraTS 2017, BraTS 2019,
and BraTS 2020 as below.

4.2 Evaluation Measures
To evaluate the performance of the developed DL segmentation model, we calculated the
ADS coefficient using Equation 2.3.
To evaluate OUR developed OST classifiers, we used ACC (Equation 2.2), and confusion
matrices. Classification ACC is a measure that summarizes the performance of a classifier as the
number of correct predictions divided by the total number of predictions.
As our data is unbalanced, we used the confusion matrix and ROC curve to evaluate and
understand the performance of the classifier as well as each classification class. The confusion
matrix allows to calculate various useful measures such as Precision, Sensitivity, Type I Error,
Type II error, F1-score in addition to ACC for each class. ROC curve is a graph measure that
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shows the performance of a classification model. This curve plots the True Positive Rate (TPR)
vs. False Positive Rate (FPR) at different classification threshold values. To implement the ROC
curve for multi-class problems, we used one class vs. all method.

Table 4.1 Characteristics of BraTS 2017, 2019, and 2020 training datasets.
BraTS

No. of samples in the

Type of MRI

dataset

MRI imaging data

modalities

No.

No. LGG

HGG

samples

Size of MRI scan

No. of HGG

Non-imaging

survival

survival

samples

information

163

Age (year),

samples
BraTS

210

75

2017

T1, T1 Gd, T2,

(240, 240, 155)

FLAIR

Overall Survival
Time (day)

BraTS

212

123

2019

T1, T1 Gd, T2,

(240, 240, 155)

212

FLAIR

Age (year),
Resection Status,
Overall Survival
Time (day)

BraTS
2020

236

133

T1, T1 Gd, T2,
FLAIR

(240, 240, 155)

236

Age (year),
Resection Status,
Overall Survival
Time (day)
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4.3 Performance of the OST Prediction System using BraTS 2017 Dataset
Various types of radiomic features extraction methods were proposed and developed based
on the BraTS 2017 training dataset such as, volumetric, texture, histogram and deep learning
(presented in chapter 3). These features and various ML methods such as SVM, KNN, LR, and
Linear Discriminant (LD), were used to train multi-classes OST classifiers. The BraTS 2017
training dataset consists of segmentation data and survival information. The segmentation data
contains two groups of mpMRI scan: HGG, and LGG. Each sample (i.e., patient) has four
structural MRI modalities with a segmentation labels file. The Survival data consists of 163
samples with non-imaging clinical data. Each sample of the survival data is an HGG patient which
has four MRI modalities with a segmentation labels file as an imaging data, and clinical nonimaging data that includes patient’s age and overall survival time information, as presented in
Table 4.1. In general, MRI scanners add noise to the raw MRI data [222, 223]. Thus, Wavelet
Transform (WT) was used in the preprocessing stage to denoise MRI scans and to improve the
quality of texture features. We also studied the effect of the denoising process on the classifier
performance. Four main experiments were conducted to develop an efficient OST classification
system based on the BraTS 2017 dataset as below. Each experiment was based on a specific type
of the proposed radiomic features

4.3.1 Volumetric and Location Features
The eight radiomic features based on volumetric and location information (described in
Section 3.2.1.1) were calculated from MRI segmentation labels file for each GBM sample (i.e.,
patient): RWT/B, RNET/WT, RED/WT, RET/WT, Distance, X-direction, Y-direction, and Z-direction. In
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addition, a non-imaging feature, patient’s age, was added in the feature fusion step to the radiomic
features. This resulted in a feature vector size of nine features (eight radiomic features and one
clinical non-imaging feature). To develop an efficient OST prediction system, various
combinations of feature fusions (radiomic and non-imaging features) were prepared to train
classification models using different types of ML methods. Table 4.2 displays the models that
achieved the best performance based on different combinations of the proposed radiomic and nonimaging features.
To avoid overfitting problems and to tune model parameters, two validation methods were
used in the training process: hold-out, and n-folds cross validation methods. Two models based on
complex and median tree ML methods with four volumetric features achieved the best predictions
with accuracy 62.5 % when 15% of the training data is used as hold-out validation set, as displayed
in Table 5.2; In addition, the best performance based on five-folds cross validation method was
achieved by using Cosine KNN classifier, and six radiomic features and patients’ age. Where two
location features, the x-direction and y-direction features, were removed from the original features
vector as described in Table 4.2.
To understand the performance of the OST classifier, confusion matrices are used as another
evaluation method to study the performance of each class in addition to the system performance,
as shown in Figure 4.1. The confusion matrices show that the class 2 (mid-term) has the worst
compared to class 1 and class 3. It is obvious that the bad prediction rate of class 2 caused reduction
in the overall system accuracy.
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Table 4.2 Classification accuracy using volumetric and location feature based on three
classification classes [64]. R refers to ratio.
No. of

Description

# of Folds

Best ML

Accuracy

All features

5

Linear SVM

48.5%

5

Coarse Gaussian SVM

49%

5

Cosine KNN

50.9%

The distance, R total tumor, R

15% hold out

Complex and median

enhanced tumor, and R core

validation

Features

9

Using absolute for the location

9

features
x-direction and y-direction were

7

4

removed

tree

62.5%

T1

73%

17%

10%

T1

75%

8%

17%

T2

35%

24%

41%

T2

56%

24%

21%

T3

26%

21%

53%

T3

37%

13%

50%

P1

P2

P3

P1

P2

P3

(a)

(b)

Figure 4.1 Confusion matrix a) for nine features and an ensemble (RUS-boosted trees)
classifier accuracy (50.8%), and b) for six features and a cosine KNN classifier with accuracy
(52.5%) [64].
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Moreover, we conducted experiments based on the volumetric and location features and
binary classifier instead of multi-classes classifier to study the performance improvements upon
using two classification tasks. The binary classifier only has two groups of survivors: short-term
(<18 months), and long-term (≥18 months). We found that the binary classifier achieved better
predictions (accuracy 68.8%) than the multi-classes classifier when 5-fold cross validation method
was used, as shown in Table 4.3. This is likely due to more classification samples being available
to train each class in the binary classifier than multi-classes classifier; in addition, the correlation
between features of two classes could be less than three classes, especially the time period of two
classes is less compared to the three classes. Figure 4.2 shows that class 1 achieved better
predictions than class 2.

Table 4.3 Classification accuracy using volumetric and location features based on a binary
classifier and 5-cross fold validation method [64].
No. of
Features

Description

No. of
Folds

Best ML

Overall
accuracy

9

using absolute for the location
features

5

Logistic regression

68.8%

9

using absolute for the location
features

5

Logistic regression

68.8%
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T1

79%

21%

79%

21%

T2

42%

58%

58%

42%

P1

P2

TPr

FNr

Figure 4.2 Confusion matrix for nine features and logistic regression classifier with 5-fold
accuracy (68.8%) [64]. When the variables “T”, “P”, “TPr”, and “FNr” refer to Target and
Prediction, true positive rate, and false negative rate, respectively.

4.3.2 Statistical and Intensity Texture Features
As the whole glioma tumor is visible in FLAIR MRI modality, radiomic statistical and
intensity texture features were extracted from this specific scan. Thirteen statistical and intensity
texture features (presented in Chapter Three) were extracted from each slice of a FLAIR MRI
scan. This resulted in a texture features vector size 20,15 (13×155). To reduce the dimensionality
of the features vector and to choose robust features, the Principle Analysis Component (PCA)
method was applied. The new robust features were used to train a three-class classifier. Howerver,
this classifier achieved low accuracy which did not acced 46% [64].

4.3.3 Histogram-based Features
The histogram features were calculated from FLAIR MRI modality. The BraTS challenge
used the FLAIR modality as it is the best MRI scan that visualizes the whole glioma brain tumor
compared to all other structural MRI modalities [30, 31, 107]. The best classification accuracy
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based on histogram features did not exceed 53%, and 42% when 10 % hold-out validation method,
and 10-folds cross validation method were applied, respectively, as shown in Table 4.4. In
addition, we developed a binary classifier that classifies a GBM patient into one of the two
survivors’ groups: short-term (<18 months), and long-term (≥18 months). The performance was
improved when a binary classifier was used and the best classification accuracy was 65% for both
KNN, and linear SVM methods, as shown in Table 4.4. In addition, we implemented feature
fusions of the eight volumetric and location features, histogram features and patients’ age to
increase the value of the features vector. We used this combination of features to develop an OST
classifier based on three groups survivors (short-term, mid-term, and long-term) as well as two
survivor groups (short-term, and long-term). We found this combination did not improve the
performance of the three-class classifier, but it increased the accuracy to 68.4% in the binary
classifier. Confusion matrices for the binary classifier based on histogram features and feature
fusion are shown in Figure 4.3.
Based on the above, the performance of the OST prediction system based on the threeclasses classifier reflects ineffectiveness of the histogram features to predict prognosis outcomes
for GBM patients using ML methods. However, the histogram distributions of the BraTS MRI
images show that MRI images are noisy data [64]. The histogram distributions for all samples of
BraTS 2017 MRI training dataset are presented in Appendix B. These histogram distributions
confirm the fact that MRI scanners add the Rician or non-central Chi noise to MRI images. The
single-coil MRI scanner adds Rician noise and the multi-coils MRI scanner adds the non-central
Chi noise [222, 223]. This complex noise distribution is due the WGN in both real and imaginary
raw MRI signals that were converted to Rician or non-central Chi when the magnitude MRI image
is created. We used DWT as a denoising method to remove the Rician/non-central Chi noise from
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MRI images. To produce best denoised MRI images, we used two types of Daubechie (db) wavelet
functions, db2 and db4, based on different denoising levels. Figure 4.4 shows an example of
denoising an MRI FLAIR image from the BraTS 2017 training dataset using db 2- Level 2 DWT
[136].
We expect that denoising MRI images will not only enhance the quality of MRI images but will
also increase the value of histogram features. Thus, the main objective from the denoising MRI
scans is to improve the performance of the OST classifier by increasing the value of histogram
features. The signal-to-noise ratio (SNR) and mean square error (MSE) are the most common
measures that are used to evaluate denoising process. However, it is not possible to calculate these
measures for denoised MRI images as the pure MRI information are not available. Therefore, we
used the accuracy of the OST prediction model based on ML methods to evaluate the performance
of the denoising process as well as the prediction process. We found that the accuracy of the OST
classifier was improved when denoising DWT was involved in developing the OST system, as
presented in Table 4.5.
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Table 4.4 Classification accuracy for classification models based on histogram features, and
combination of histogram, volumetric and location feature [64, 136].

Type of Features

Histogram + Age
Histogram + Age

Type of the OST
classifier
Three-classes

Best ML

Validation
method

Overall
accuracy

Simple Tree

10-folds cross
validation

41.5%

KNN

10% hold-out

53.3%

KNN

10-folds cross
validation

65%

SVM
(median
Gaussian)

10-folds cross
validation

65%

SVM
(linear)

10-folds cross
validation

68.4%

Three-classes
Two classes

Histogram + Age

Two classes
Histogram + Age
Volumetric &
location+
Histogram + Age

Two classes

T1

71%

29%

T1

70%

30%

T1

80%

20%

T2

34%

66%

T2

40%

60%

T2

50%

50%

P1

P2

P1

P2

P1

P2

(a)

(b)

(c)

Figure 4.3 Confusion matrices for hisogram features using binary classifiers with threshold
time eighteen months using, a) weighted KNN, b) median Gaussian SVM, and c) linear SVM
[64].
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MRI sample from BraTS data

2D DWT-Level 2

Denoised Image

Figure 4.4 Denoising MRI image using db2 wavelet transform-Level 2 [136].
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Table 4.5 Classification accuracy for the best OST prediction models based on denoised
MRI images using DWT and histogram features [136].
Denoising
function/ Level

Features

Histogram +
Db4/L4

Db2/L1

Best ML

SVM (Linear)

Age
Histogram

Overall

method

accuracy

10-folds cross
validation

Simple Tree

10-folds cross
validation

Db2/L4
Histogram +
Db2/L3

Validation

Simple Tree

Age

10% hold-out

44%

44.7%

66.7%

4.3.4 Radiomics Deep Learning Features
As the size of the dataset is small, DL classifiers are improper to develop the OST
prediction system for GBM patients based on three classification classes. DL algorithms are the
best prediction methods that can develop numerous of meaningful low-level and high-level
descriptors (features) during the training process. In other words, these prediction methods do not
require a preprocessing step to extract meaningful features from images to train prediction models.
Therefore, the DL methods has been used widely to extract meaningful features from the data,
called DL features, by using a well pre-trained DL classifier such as AlexNet. However, the
AlexNet was not trained to perform a classification task in volumetric medical imaging data such
as MRI images. Therefore, we prepared a total of 3,703 2D samples, that contain the three-brain
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tumor sub-regions, from the 136 MRI scans with GBM tumor. The 2D brain tumor region is
considered as a ROI to extract the 2D DL radiomic features. As the size of AlexNet input patch is
224 × 224 × 3, the three MRI modalities (T1 Gd, T2, and FLAIR) were used as the three channels
and all the prepared samples were resized to size 224 × 224 to be compatible with input size of
AlexNet. 4096 DL radiomics features were extracted from layer 7, which is the Fully Connected
Layer before output layer (classification layer), to prepare a DL features vector. Various ML
methods were used to develop the OST classification system based on DL radiomic features. We
divided the prepared data randomly into two datasets: train/validation dataset, and test dataset.
75% of the prepared samples were randomly selected for the train/validation process, while the
remaining 25% samples were used for the test process. We used the 5-fold cross-validation method
to train the prediction system using the train/validation dataset. The best train/validation
performance was achieved by LD classifier and linear SVM classifier with accuracy 91% and 86%.
However, the best performance on the test dataset was achieved by LD with accuracy 55%. Figure
4.5 displays the confusion matrices for these two models.
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Figure 4.5 Confusion matricies based on radiomics DL features on train/validation dataset that
trained by a) linear SVM classifier, and b) LD classifier [64] .

4.4 Performance of the OST Prediction System using BraTS 2019 Dataset
BraTS 2019 released medical imaging data to segment glioma tumor subregions, including
HGG and LGG tumors, from MRI scans. In addition, they included survival data for samples with
HGG tumors, specifically GBM tumor type, to predict patients’ Overall survival time. The
multimodal medical imaging data consists of 3D four MRI modalities (T1, T2, T1 Gd, and FLAIR)
with segmentation labels for 335 patients (i.e., samples), as presented in Table 4.1. When 212
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samples are HGG, and each HGG patient (i.e., sample) has survival non-imaging data that contains
the patient’s age in years, survival time in days, and resection status. An HGG patient has one of
the three categories of resection status: gross total resection (GTR), subtotal resection (STR), and
unknown resection status. Table 4.6 lists the detailed information of the BraTS 2019 dataset, and
Figure 4.6 shows the distribution of the survival data with respect to the survival time in days and
months. This dataset was used to develop the OST prediction system using volumetric and location
radiomic features that were extracted based on brain function regions [138], as shown Figure 4.7.
The following three groups of radiomic features based on volumetric and location information
were extracted from two brain sub-volumes using BraTS 2019 dataset: mid-Sagittal, mid-Coronal,
and mid-Horizontal. To produce the best OST prediction system, three experiments using various
ML methods were conducted based on a classification process to develop many prediction models.
These models were used to classify a GBM patient into one of the three survival groups: shortterm survival (<10 months), mid-term survival (10-15 months), and long-term survival (>15
months). To avoid overfitting, 70% of the survival data samples were selected randomly for the
train/validation process using 5-fold cross validation, while the remaining 30% of samples were
used for the test process.

134

Table 4.6 Characteristics of the survival BraTS 2019 dataset. Resection status (ReS),
short-term (StT), mid-term (MdT), long-term (LgT). The alive sample was discarded
from the computations [138].
Parameter

n

Patients

212

Dead patients

211

Alive patients

1

Patients with StT

81

Patients with MdT

55

Patients with LgT

76

Patients with GTR ReS

102

Patients with STR ReS

3

Patients with Unknown ReS

107

Patients with StT in GTR group

35

Patients with MdT in GTR group

27

Patients with LgT in GTR group

39
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(a)

(b)
Figure 4.6 Survival distribution for BraTS 2019 dataset, (a) patients’ age and the overall
survival time, (b) number of patients in each month [138].
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BraTS DATA
Imaging data

Non-imaging data

Resection status
Age (Year)

Survival time (Day)

Mid-Sagittal

Mid-Coronal

Mid-Horizontal

Features Extraction Method
•
•

Volume &
Location

• Resection status
• Age

Machine Learning Algorithms

Short-term
<10 months

Mid-term
10-15 months

Long-term
>15 months

Figure 4.7 The OST prediction system using radiomic features based on volumetric
information and non-imaging information.
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4.4.1 Volumetric and Location Features
Three groups of radiomic features based on volumetric and location information were
extracted from two brain sub-volumes using BraTS 2019 training dataset, as presented in Section
3.2.1.2. These three groups are mid-Sagittal, mid-Coronal, and mid-Horizontal. In each of these
groups, twelve radiomic features based on volumetric and location information, as listed in Tables
3.2-3.4, were extracted from segmentation labels files. We used six ML methods, (NN, SVM,
tree, naïve Bayes, LD, and KNN), to develop the OST classification model for each of the three
groups of the radiomic features. Several configurations were implemented to produce the best
prediction model for each ML method. The classifiers’ performance of the best ML methods for
each of the three groups of radiomic features are listed in Tables 4.7-4.9 These results show that
the NN classifier achieved the best accuracy compared to other types of ML methods for all three
groups of radiomic features.
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Table 4.7 Performance of the best OST prediction systems, using radiomic features based
on mid-Sagittal plane and various ML methods [138].

No. of Features

ML Method

Overall
Accuracy

NN (hidden nodes = 150)

53.3%

SVM (fine Gaussian)

44.3%

KNN (weighted)

49.5%

Naïve Bayes (Gaussian)

43.9%

LD

54.8%

Tree (ensemble)

46%

12
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Table 4.8 Performance of the best OST prediction systems, using radiomic features based
on mid-Coronal plane and various ML methods [138].

No. of Features

ML Method

Overall
Accuracy

NN (hidden nodes = 50)

53.3%

SVM (fine Gaussian)

45.3%

KNN (coarse)

44.3%

Naïve Bayes (Gaussian)

42.5%

LD

43.4%

Tree (fine)

39.2%

12
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Table 4.9 Performance of the best OST prediction systems, using radiomic features based
on mid-Horizontal plane and various ML methods [138].

No. of Features

ML Method

Overall Accuracy

NN (hidden nodes = 40)

53.2%

SVM (fine Gaussian)

48.6%

KNN (weighted)

49.5%

Naïve Bayes (Gaussian)

39.6%

LD

42%

Tree (boosted)

42%

12
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4.4.2 Feature Fusion of Volumetric and Location Information and Patients’ Age
As reported by other studies, the survival rate of GBM patients was correlated with the
patients’ age, and it is better in young people than old people [16-18]. Thus, a non-imaging feature,
the age factor, was combined with the twelve volumetric features that were used in Section 4.3.1,
to increase the performance of the OST prediction model based on NN classifier. In other words,
feature fusions based on imaging information and non-imaging information were performed in the
preprocessing step to increase the meaning of features as well as the performance of the OST
prediction system. To avoid complexity as the size of the training data is small, a simple NN
architecture was developed to train the prediction model. This classifier consists of an input layer,
a one hidden layer, and an output layer, as shown in Figure 4.8 The size of the input layer is 13
features, equal to the size of the radiomic and non-imaging features vector. The output layer
consisted of three outputs, one for each classification class: short-term, mid-term, and long-term.
The activation functions are hyperbolic tangent sigmoid (tanh), and the softmax for the hidden
layer and classification (output) layer, respectively. To tune the size of the hidden layer (i.e.,
number of NN nodes), several configurations were performed for the three groups of features. The
BraTS training dataset is divided into three sets: training (70%), validation (15%), and test (15%)
Table 4.10 lists the performance of the best configurations of prediction models based on the three
groups of features.
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Figure 4.8 Simple neural network. f1 is tanh, and f2 is softmax.

Table 4.10 Performance of the best OST prediction systems using volumetric, location
features with age factor based on NN.
No. of
Features

13

Training

Validation

Accuracy

Accuracy

50

62.3%

56.3%

65.6%

63.3%

Mid-Coronal

50

62.2%

56.3%

56.3%

60.4%

Mid-Horizontal

150

68.2%

50%

62.5%

64.6%

Approach

No. of Nodes

Mid-Sagittal
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Test

Overall

Accuracy Accuracy

4.4.3 Feature Fusion of Volumetric and Location Information and Non-Imaging Features
A study reported that the surgical treatment was associated positively with survival rates
for GBM patients [27]. Consequently, to improve the performance of the OST classifier based on
NN, another clinical non-imaging feature was added to the feature vector in the section 4.3.2 for
the three sets of the radiomic features. This feature fusion process was performed in the
preprocessing step to increase the quality of training information by combining medical imaging
features with clinical non-imaging features. This resulted in increasing the size of the features
vector to 14 features which includes two clinical non-imaging features (Resection Status and Age),
and twelve radiomic features based on volumetric information. These new groups of features were
fed to the simple NN classifier to train reliable prediction models. We used tanh and softmax
activation functions in the hidden layer and output classification layer, respectively. The best
developed OST classification models based on feature fusions for the three groups of features
(mid-Sagittal, mid-Coronal, and mid-Horizontal) are listed in Table 4.11. Confusion matrices and
receiver operating characteristic curves (ROCs) are used to provide better understanding of the
performance of the three classifiers (mid-Sagittal, mid-Coronal, and mid-Horizontal) that
presented in Table 4.11, as shown in Figures 4.9 - 4.11.
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Table 4.11 Performance of the best OST prediction systems using volumetric and location
features with age and resection status factors based on NN.
No. of
Features

14

No. of

Training

Validation

Test

Overall

Nodes

Accuracy

Accuracy

Accuracy

Accuracy

Mid-Sagittal

100

66.9%

65.6%

56.3%

65.1%

Mid-Coronal

200

64.9%

59.4%

59.4%

63.2%

Mid-Horizontal

100

66.2%

53.1%

62.5%

63.7%

Approach
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Receiver operating characteristic curves

Confusion matrices
Figure 4.9 The receiver operating characteristic curves and confusion matrices for
fourteen feature fusions based on mid-Sagittal group [138].
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Receiver operating characteristic curves

Confusion matrices
Figure 4.10 The receiver operating characteristic curves and confusion matrices
for fourteen feature fusions based on mid-Coronal group [138].
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Receiver operating characteristic curves

Confusion matrices
Figure 4.11 The receiver operating characteristic curves and confusion matrices for
fourteen feature fusions based on mid-Horizontal group [138].
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4.5 Performance of the OST Prediction System using BraTS 2020 Dataset
In 2020, the BraTS challenge increased the size of the training medical imaging data to 369
samples (i.e., patients) of HGG and LGG tumors; when the size of HGG group is increased to 236
samples (i.e., patients), as presented in Table 4.1. Each sample of imaging data consists of four
preoperative 3D MRI modalities (T1, T2, T1 Gd, and FLAIR) with segmentation labels files.
Clinical non-imaging data which includes survival time, resection status and patients’ age, were
provided for HGG patients. To produce an efficient automatic OST prediction system based on
classification task, we developed two types of radiomic features: volumetric and location features,
and shape features. These features were used to describe the size, location, and shape of the whole
glioma brain tumor as well as the tumor sub-regions: WT, ET, NCS, and TC. Figure 4.12 shows
the steps of developing the OST classification system based on the BraTS 2020 dataset. To
segment glioma brain tumor sub-regions, the multimodal preoperative MRI scans with
segmentation labels files were used to develop automatic segmentation models based on the DL
method. Then we calculated the shape, volume, and location information from the segmentation
results that were obtained by the DL segmentation model. The radiomic features were used to
develop an automatic OST prediction system based on a three-class classification task to classify
a GBM patient into one of the three groups of survivors: short-term, mid-term, and long-term. To
improve the performance of the OST classifier, we used feature fusions and ensemble models as
preprocessing and postprocessing methods, respectively. We evaluated our developed OST
prediction system in the BraTS 2020 validation and the BraTS 2020 test datasets, which both are
unlabeled data. The evaluation process was performed by BraTS challenge 2020 after we uploaded
our brain tumor segmentation results as well as OST classification results. Various experiments
were implemented to develop the best OST prediction system based on classification task which
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was developed to classify a GBM patient into one of the three survivor terms: short-term (<10
months), mid-term (10-15 months), and long-term (> 15 months).
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Figure 4.12 Automatic overall survival time prediction system based on volumetric, shape,
and location radiomic features [138].
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Four main experiments were conducted to develop an efficient OST classification system.
The first experiment focused on developing a reliable DL segmentation model. The second
experiment involved volumetric and location radiomic features to develop an efficient OST
prediction system. The third experiment used shape and location radiomic features to develop an
efficient OST prediction system. The fourth experiment focused on involving preprocessing and
postprocessing steps to improve the performance of a prediction system.

4.5.1 3D Deep Learning Segmentation Model
In this experiment, we developed a modified 3D U-Net model that was presented in Section
3.3 to produce an automatic segmentation system based on convolutional neural network (CNN)
structure. We used this segmentation system as a processing step to identify and localize the
glioma brain tumor sub-regions in MRI images. We then used the segmentation results to calculate
the size, shape, and location information of the glioma tumors for each patient to develop an OST
prediction system. We fed one of the four MRI modalities (T1, T2, T1 Gd, and FLAIR) to each
input channel of the 3D U-Net model. As the size of the glioma tumor as well as the tumor subregions are small compared to the whole brain region, the BraTS MRI data is highly imbalanced.
To manage imbalanced labels, we selected patches size (64 × 64 × 64) that contain the tumor subregions as well as healthy tissues from each MRI modality. The size of each patch is 64 × 64 × 64
× 4 because we have four mpMRI scans for each patient (i.e. sample). When each patch contains
the compatible corrupted volume from the four MRI modalities. This step is important to avoid
overfitting that occurs due to imbalanced labels in a segmentation dataset. To improve the quality
of the training data, and to increase the convergence of the training process, channel normalization
method was applied on each input channel in the pre-processing step. This step is important to
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standardize multi-source data. In addition, to speed up the training process in terms of a model
convergence, we used mini-batch technique. In addition, the training process was performed by
using the ADAM optimizer with the GDL to solve imbalanced data. We randomly divided the
corrupted patches into three sets: train, validation, and test. To train the segmentation model, we
used the training process parameters that are listed in Table 4.12.

Table 4.12 DL model parameters for training process [137]
Optimizer

ADAM

Mini-batch

4 or 8

Initial learning rate

10−4

Learning rate drop factor

0.95 drop each 5 epochs

Maximum number of training epochs

100

The performance of the best segmentation models is reported in Table 4.13; Figure 4.13
shows examples of ground truth MRI images and segmentation predictions for samples in test
group of BraTS 2020 training dataset using the three segmentation models in Table 4.13. As
mentioned in Chapter three that the BraTS challenge released two unlabeled datasets, the BraTS
2020 validation and BraTS 2020 test datasets, for validation and test phases. The BraTS validation
phase data was released to evaluate prediction models that were developed based on the BraTS
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2020 training dataset. As our 3D U-Net AE model achieved the best segmentation results for the
three brain tumor regions (WT, ET, and TC), shown in Table 4.13, we used it in the BraTS 2020
validation and test phases to extract radiomic features based on volumetric, shape and location
information. Figure 4.14 shows the 2D and 3D segmentation predictions for a sample from BraTS
2020 validation dataset.

Table 4.13 Performance of the three developed segmentation models based on
modified 3D U-Net. [137]
Model

# Mini batch

ADS WT

ADS TC

ADS ET

Model 1: 3D U-Net

4

0.85809

0.87336

0.85511

Model 2: 3D U-Net

8

0.86306

0.86752

0.85054

Model 3: 3D U-Net AE

8

0. 8898

0. 88197

0. 85248
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GT

Model 3

Model 2

Model 1

Figure 4.13 3D segmentation results of two samples from BraTS 2020 train dataset (test
set-unseen). The colored regions represent three brain tumor sub-regions as follows: Red
for necrotic and non-enhancing tumor core, Green for enhancing tumor core, Yellow for
peritumoral edema.
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Four MRI modalities

Segmentation Predictions using Model 3
2D predictions (Slice 89)

3D predictions

Figure 4.14 Four MRI modalities and segmentation predictions for the sample
BraTS20_Validation_008 [137].
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4.5.2 OST Prediction Model based on Volumetric and Location Radiomic Features
The radiomic features based on volumetric and location information using 4 brain subvolumes and 8 brain sub-volumes approaches were used in this experiment. These features are
presented in Section 3.2.1.2. These two approaches are the expanded version of the two subvolumes that were developed and tested using the BraTS 2019 dataset. We expected that increasing
the size of the feature vector by using the four and eight brain sub-volumes feature extraction
methods could improve the results that were achieved by two sub-volumes methods. As the NN
classifier (Figure 4.8) achieved the best predictions compared to other ML classifiers, we used it
to develop the OST prediction system in the BraTS 2020 dataset. The size of input layer is 22 and
42 features in the four sub-volumes and eight sub-volumes methods, respectively. The same
activation functions were used in this experiment, tanh and softmax for the hidden layer and
classification (output) layer, respectively. Several configurations were performed for these two
approaches of radiomic features to tune the size of the hidden layer (i.e., number of NN nodes).
The BraTS 2020 training dataset is divided into three sets: training (70%), validation (15%), and
test (15%). The best classification models based on feature fusions of these two approaches and
non-clinical imaging features are listed in Table 4.14.
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Table 4.14 Performance of the best OST prediction models in terms of accuracy in the
BraTS Train 2020/Validation2020 datasets [137].
BraTS 2020 Train Dataset
Model name

Features type

and type

Validation

Nodes

Dataset

(No. Features)

M1

4V+ Non-Imaging

BraTS 2020

No. Hidden

Train

Validation

Test

Total

ACC%

ACC%

ACC %

ACC %

ACC %

150

73.5

57.1

54.3

68.2

51.7

200

68.1

68.6

62.1

67.4

48.3

60

62.7

62.9

54.3

61.4

55.2

400

74.7

48.6

65.7

69.5

48.3

100

75.3

54.3

54.3

69.1

51.7

(24)
M2

8V+ Non-Imaging
(44)

M3

Shape+ Non-Imaging
(30)

M4

4V+8V+ NonImaging
(66)

M5

4V+ shape+ NonImaging
52

M Ensemble
(M1&M3)

(V4+shape+Non-

55.2

Imaging) & (shape)

4.5.3 OST prediction model based on Shape and Location Radiomic Features
In this experiment, we calculated the shape and location features that were presented in
Section 3.2.2. We used the same NN classifier of the previous experiment with the same activation
functions. To improve the performance of the OST prediction classifier, we implemented feature
fusions of radiomic features based on shape and location information and clinical non-imaging
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features (patients’ age and resection status). Table 4.14 lists the best predictions model based on
radiomic features.

4.5.4 OST Prediction Model based on Feature Fusions and Ensemble Model
To improve the performance of the OST classifier, preprocessing and post-processing steps
were involved. In the preprocessing step, we applied two different types of feature fusions of
radiomic features (volumetric and shape) as well as non-imaging features to improve the meaning
of the feature vector. The new feature vector was used to train the OST prediction system based
on a classification task. In addition, we used ensemble models in the post-processing step to
improve the results of the OST prediction system. Table 4.14 lists the best models that were
developed using feature fusions and ensemble models. The Ensemble model was tested in the
validation unlabeled dataset, and used in the BraTS test phase. To clarify the performance of each
class, confusion matrices and ROC curves were used to test the four brain sub-volumes, shape,
and feature fusion of volumetric and shape models, as shown in Figures 4.15-4.17.
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Figure 4.15 ROC curves and confusion matrices for feature fusion model based on
volumetric features (4 sub-volumes) and non-imaging features [137].
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Figure 4.16 ROC curves and confusion matrices for feature fusion model based on
shape, location, and non-imaging features [137].
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Figure 4.17 ROC curves and confusion matrices for feature fusion based on volumetric,
shape, and location [137].
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Chapter 5- Conclusions and Future Work

5.1 Introduction
In this dissertation, we developed and validated an automatic OST predictions system for
patients with GBM tumors as a CADiag. We developed this system to be used as a fast, accurate,
and inexpensive assistant diagnosis method to support and improve the medical decision making,
increase understanding of the tumor behavior, and improve patients’ health. In this chapter, we
discuss the results of the developed automatic OST prediction system for patients with GBM brain
tumors that were presented in Chapter four. We also conclude our main achievements toward
understanding the behavior of GBM brain tumors. In addition, we recognize the potential future
research directions to improve the performance of the developed OST prediction system.

5.2 Conclusions
GBM is a grade IV glioma, the most aggressive brain tumor. Patients with GBM have poor
prognosis outcomes and low survival rates [14, 15]. Predicting prognosis outcomes is crucial to
increasing the understanding of tumor behavior, which is essential to decide an effective treatment
plan, and to improve patients’ health. Therefore, this dissertation focuses on developing an
automatic OST prediction system for patients with GBM brain tumors using medical imaging and
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non-imaging data. Various testing methods are required to diagnose a brain tumor, such as
neurological exams, imaging tests, and biopsy tests [26-28]. The imaging test is essential to define
the size and location of brain tumors [27]. The MRI imaging test is characterized by perfect tissue
contrast, which provides better visualization of the complexity and heterogeneity of a brain tumor
[27, 29]. Thus, the MRI is considered the gold standard of imaging tests to identify the size and
location of brain tumors. The BraTS dataset is a well generalized and labeled data [31, 107], thus,
we used it to develop the OST prediction system based on the supervised learning method. The
dataset consists of mpMRI scans and clinical information such as survival time, patients’ age, and
resection status. The size of the BraTS training dataset, in terms of number of samples, is small
[30, 31], therefore, it is not suitable to use DL methods in developing the OST prediction system.
We used ML methods (traditional ML) to develop the OST prediction system based on a
classification task. This prediction system classifies a patient into one of three survival time terms:
short-term (<10 months), mid-term (10-15 months), and long-term (>15 months) [64, 136-138].
Table 4.6 shows that the number of samples in each of these overall survival groups is limited, and
Table 4.1 illustrates that the size of a single imaging sample, which contains the four MRI
modalities (T1, T1 GD, T2, FLAIR), is huge (240×240×155×4) to train an ML classifier.
Therefore, we proposed and developed various feature extraction methods to extract meaningful
information from medical images, called radiomic features. In fact, feature extraction methods are
used to reduce the dimensionality of the input samples to make it suitable for the ML classifier
with small dataset. Patients’ overall survival time and the size, shape and location of the GBM
brain tumors are related [130, 131]. Furthermore, appearance and size of a specific glioma brain
tumor sub-region are also correlated with patients’ overall survival rates [130, 182, 187, 188].
Hence, we proposed and developed novel feature extraction methods based on shape, size, and
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location of GBM sub-regions to train the OST classifier [64, 136-138]. To produce the best OST
prediction system, we also proposed features extraction methods based on texture, histogram, and
DL features. We used the BraTS 2017 dataset to develop the OST prediction system using four
types of feature extraction methods (volumetric and location, texture, histogram, and DL features).
Past investigations considered the relation between patients’ survival rate and age [18, 19, 49,
133]. Therefore, we added the age as a non-imaging factor to the radiomic features. Developing a
reliable OST prediction system for patients with GBM tumors using a specific ML is a complex
task, especially with dataset like the BraTS 2017, which has small number of samples. To the best
of our knowledge, there was no studies that developed an OST prediction system for patients with
GBM brain tumors using radiomic features before 2017 as the BraTS survival data was released
in 2017. All our proposed and developed features extraction methods on BraTS 2017 are thus
novel methods. We used many configurations of various ML methods to develop a reliable OST
prediction system based on a classification task. Although the OST classifier based on DL features
yielded higher accuracy with the training dataset (91%), it showed overfitting with a low accuracy
55% on the test dataset [64]. The best classification performance on the BraTS 2017 dataset was
achieved by using four volumetric features and Tree ML method with accuracy of 62.5% when 15
% hold-out validation was applied, as displayed in Table 4.2. The prediction model based on the
histogram features achieved better accuracy than texture features, but did not exceed 53.5% when
KNN and 10% hold-out validation were used to train the classifier [64]. However, the histogram
features showed that the MRI data contains noise [64, 142]. Thus, we used the wavelet transform
as a denoising method to improve the quality of the MRI data as well as to boost the classification
accuracy. The classification accuracy after applying the denoising method increased to 66.7 %
when simple Tree and 10% hold-out validation method were used to train the classifier based on
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histogram features. Hold-out validation training is not the best suitable validation method for small
datasets. K-fold cross-validation is an efficient way to validate a reliable OST prediction system,
and prevent overfitting. Based on our experiments on the BraTS 2017 dataset, the best OST
prediction system was based on volumetric features and histogram features combined with
patients’ age.
The BraTS 2019, and 2020 datasets contain more samples, and the resection status
information for each patient was added as a new survival time information. Qin et al. found that
the surgical treatment delayed the recurrence of GBM and increased survival time [134].
Therefore, we decided to add the resection status information of each sample (i.e., patient) as a
non-imaging feature to the radiomic features. We planned to use binary representation to perform
the resection status feature in the feature vector: the value 1 refers to GTR resection status, and the
value 0 refers to the STR resection status. However, the BraTS challenge 2019 and 2020 evaluated
the prediction results for the GTR samples only in the training and validation phases, and the test
data contained patients with the GTR resection status only. Table 4.6 shows that the number of the
samples in the BraTS 2019 with GTR in the short-term, mid-term, and long-term survivor groups
are 35, 27, and 39, respectively. We believed that it is unreliable to train a complex a multi-class
prediction system using very small data with the GTR resection status only. Therefore, we used
all samples to train our prediction system, and we involved a resection status feature as an
additional non-imaging features, along with patients’ age. However, Table 4.6 shows that only
102, and 3 samples (i.e., patients) are with GTR, and STR, respectively. In addition, there are 107
samples (i.e., patients) with unknown resection status [144]. Thus, we used a binary representation
for the three resection statuses; the value 1 refers to patients with the GTR resection status, and the
value 0 refers to patients with either the STR or unknown resection status. We studied the relation
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between the survival time and the size and appearance of the GBM brain tumor with respect to the
brain functionality structure. Our plan was to extract the volumes of the whole tumor and tumor
sub-region from each brain functional area to train the OST classifier. However, we did not find a
proper software program to recognize automatically each of these function regions in MRI scans.
Thus, we decided to use the brain sectional planes to divide the brain volume in MRI images into
sub-volumes. In the BraTS 2019, we proposed and developed a novel method to extract the
volumetric and location features based on two brain sub-volumes. Three approaches were used to
divide a brain volume into two sub-volumes by using the three brain mid-section planes: midSagittal, mid-Coronal, and mid-Horizontal [138]. We implemented various configurations using
different ML methods for each of the three approaches to develop a reliable OST prediction
system. We found that simple NN based on the radiomic features achieved the best performance
for the three approaches, as displayed in Tables 4.7, 4.8, and 4.9. Then we added patients’ age as
a non-imaging feature to the features vector, and we used NN to train a prediction model for each
of the three approaches. We found that both the test and overall prediction accuracies were
improved after combining the age feature, as presented in Table 4.10. This experiment proved that
patients’ age is associated with patients’ overall survival time. Then we added a resection status as
a second non-imaging feature to the features vector along with the age feature. Table 4.11 showed
that the test accuracy of mid-Coronal and mid-Horizontal OST classifiers increased slightly when
the resection status feature was involved in the training process. However, we expected better
improvement in the accuracy based on Qin et al. study [131]. We believe that this slight
improvement is due to many samples (i.e., patients) with unknown resection status, which likely
led to unclear representation of this feature on the prediction process. We believe availability of
the resection status for all samples in the training data will not only improve the performance of
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the prediction models, but also will provide better description of the effectiveness of the resection
status on the survival rates for patients with GBM brain tumors. As the BraTS training data is
unbalanced, we used ROC curves and confusion matrices to understand the classifier performance
in terms of type I error, type II error, and prediction rate for the three prediction models (midSagittal, mid-Coronal, and mid-Horizontal), as shown in Figures 4.9-4.11. The confusion matrices
in these figures show that the types II error was higher than Type I error in the mid-term group
(class 2) for the three approaches; the type I error was less common than type II error in the shortterm (class 1) and long-term (class 3) groups for the three approaches; type I error was also less
common than type II error in the short-term group (class 1) for both the mid-Sagittal and midCoronal classification models; however, both type I and type II errors were same in the midHorizontal classifier. The ROC curves for the mid-term group (class 2) for the three approaches
were the worst compared with short-term (class 1) and long-term (class 3) ROC curves. These
ROC curves described visually the Area Under Curve (AUC) for the three approaches. From theses
ROC curves, we can obviously recognize the superior of class 1 and class 3 over class 2 in
producing better predictions for the three approaches. Three factors can be used to explain this
accuracy reduction in Class 2: unbalanced nature of the data, time period for each class, and
number of critical samples in each class. As presented in Table 4.6, the class 2 has approximately
30% less samples (i.e., patients) than class 1 and Class 3. We believe that this affected the meaning
of the developed descriptors, as well as the prediction rate of class 2. Figure 4.6-a shows that the
time period of class 2 is 6 months (month 10- month15, or day 300 - day450) which is small
compared to class 1 (9 months (month 1 – month 9, or day1 – day 299)) and Class 3 (month16 month 60, or day 451 – day 1800). The critical samples are those samples lie in the critical time
line that separate these classes. For example, the critical survival time line is month 10 (day 300)
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that separates class 2 and class 1, as shown in Figure 4.6-b; whereas the critical survival time line
is month 15 (day 450) that separates class 2 and class 3, as shown in Figure 4.6-b. There are six
patients with an overall survival time of 9 months (short-term), and two of these patients had a
survival time of 296 days which is very close to 300 days (critical survival line between class 1
and class 2), and there are eight patients with overall survival time of 16 months (long-term), and
one of these patients had a survival time of 453 days. These six patients in class 1 and two patients
in class 3 within more or less a few days, they would be considered as class 2. Furthermore, one
of the patients with a survival time of 10 months (mid-term) had a survival time of 300 days, and
two patients with a survival time of 15 months had a survival time of 448 days (mid-term). We
can also consider these two and one patients as critical samples too. We believe that the features
of critical samples could be the reason of dropping the prediction rate in the class 2 compared to
class 1 and class 3. We concluded from the results of our experiments on BraTS 2019, providing
balanced big data is important to decrease the occurrence of type I errors and type II errors, and to
boost the performance of the OST prediction system.
Due to our promising achievements on the BraTS 2019 dataset [138], we expanded our
experiments to extract volumetric features from four and eight brain sub-volumes instead of two
brain sub-volumes using the BraTS 2020 dataset. The results in Table 4.14 show that eight subvolumes classifier (model M2) outperformed the four sub-volumes classifier (model M1) in terms
of the validation, test and system overall accuracies using the BraTS training 2020 dataset. We
found that the classification performance of model M2 is better than model M1 in terms of
overfitting. We believe this superiority of model 2 is due to its ability to derive meaningful
descriptors to represent the volumetric and location information of the brain tumor with respect to
the brain functionality structure. We also studied the effect of using feature fusions by combining
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the four sub-volumes features with the eight sub-volumes features to produce a new classifier
(model M4). We found this combination increased the test accuracy but not the validation accuracy
on the BraTS training 2020 dataset. In addition, we extracted shape features to increase the value
of the radiomic features based on size and location information. Especially, some OST top rank
methods in the previous BraTS challenges used some of our shape features to develop a reliable
prediction model [65, 67, 94, 108, 112, 114]. The developed classifier based on shape features
(model M3) achieved less accuracy compare to the model M2 in the validation and test sets of the
BraTS training 2020. We also tested feature fusions of volumetric based on four sub-volumes and
shape features to develop a reliable OST classifier that we named it model M5. For further tests
and evaluations, we participated in the BraTS 2020 validation phase to test the five developed
classification models (M1, M2, M3, M4 and M5). As the BraTS validation 2020 dataset is
unlabeled data, we needed segmentation labels for each GBM sample (i.e., patient) to calculate the
volumetric, shape, and location information. Thus, we proposed and developed a novel DL model
to be used as an automatic labeling system to segment the GBM sub-regions from mpMRI scans.
We used the best segmentation model, 3D U-Net AE (M3), to perform the segmentation process in
the BraTS unlabeled validation 2020 dataset. We developed and evaluated this model by using
the labeled mpMRI scans of BraTS training 2020 dataset. We believe that the AE improved the
quality of the high-level features, which provided better representation of pixels spatial
information to boost the segmentation results. We used the segmentation results of the BraTS
validation 2020 dataset to extract the volumetric, shape, and location features for M1, M2, M3,
M4, and M5. Then we submitted the predictions of the five classifiers to the BraTS 2020 portal
system to be evaluated in the BraTS validation phase. We expected that the M2 could achieve the
best performance in the validation phase as it has better accuracy in the validation and test sets of
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the BraTS training 2020 dataset. However, the best classification performance in the validation
phase was achieved by M3 and M5. The BraTS 2020 provided a second unlabeled dataset, called
the BraTS test 2020 dataset, to test the developed prediction systems from the validation phase.
However, one submission per team was allowed in the test phase using the BraTS 2020 test dataset.
To reduce variance and increase the prediction performance [241], we used an ensemble model
which is based on decision-fusion approach. Thus, we developed an ensemble classifier of model
M3 and model M5 to predict OST for patients with GBM on the BraTS 2020 test phase. This
ensemble model obtained remarkable achievements with accuracy 55.2%, and 55.1% in the
unlabeled BraTS validation 2020 and BraTS test 2020 datasets, respectively. Although our
ensemble model did not achieve the top three rank methods in the BraTS 2020 test dataset,
performance of our model was better than the top three methods on the BraTS validation 2020
dataset [ 94, 95, 104]; the accuracy of the first, second, and third rank methods on the BraTS test
dataset was 62% [95], 58.9% [104], and 57.9% [94], respectively; while, the validation accuracies
on the BraTS validation 2020 dataset were 48.3%, 37.9%, and 53% for the third rank [94], second
rank [104], and first rank methods [95], respectively. Based on the accuracy of these top three
methods in both BraTS validation, and BraTS test 2020 datasets, our model is better in terms of
overfitting. We wished more information were provided about the accuracy of each survival time
group for these three methods to prove our expectations regarding low system performance due to
the critical samples, time period, and unbalanced data that we discussed above on the BraTS 2019
dataset.
Based on the discussion above, we summarize our conclusions as follows:
1. We developed the OST prediction system as a CADiag method to automatically estimate
patients’ outcomes from mpMRI scans and clinical non-imaging data. Our prediction
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system was developed as an assistant diagnosis method to increase the understanding of
the tumor behavior by predicting the OST, to accelerate the diagnosis process by
identifying automatically the size and location of the GBM tumors in MRI scans, and to
reduce the diagnosis cost. To develop our prediction system, we utilized the radiomic
features and ML methods. Our radiomic features and ML methods are proper to increase
our understanding about tumor behavior even in small datasets. In addition, we believe that
the prediction accuracy will increase if more data is used in the training process.
2. Critical samples can be a serious problem that cause reduction in the performance of the
OST system prediction. Developing a regression model instead of a classification model
to predict OST could be a proper solution for the critical samples problem. However, we
believe that small data is not suitable to develop an efficient regression model for complex
prediction task such as the OST prediction for patients with GBM tumors.
3. Radiomic features based on shape, size and location information of GBM tumor subregions are important to develop the OST prediction system. Especially when the age and
resection status features are involved in the training process as non-imaging features.
4. Unknown resection status for many samples in the BraTS training dataset could be the
reason for low predictions because it provided an ineffective representation of this feature
in the prediction process.
5. Information fusions which include both features-level, and decision-level fusions are
important to boost the performance of the OST prediction system.
6. DL segmentation systems are alternative, accurate, inexpensive, and fast labeling methods
to identify the size, location and shape of glioma brain tumor sub-regions in MRI scans.
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Without these methods, predictions in unlabeled MRI scans could be an extremely
expensive process.
7. Denoising method is useful to remove the redundant information that were added by the
MRI machines to the raw MRI data. These methods are useful to improve the quality of
histogram-based features but not the quality of the volumetric, size, and location features.
The quality of the volumetric, shape, and location features depends on the segmentation
predictions from DL, and the effectiveness of the feature extraction methods.
8. Preprocessing methods that were developed in this dissertation, such as feature fusions,
feature extraction, denoising, automatic DL labeling methods are essential to develop
automatic and efficient prediction models based on ML methods for complex tasks.

5.3 Future Work
Predicting prognosis outcomes such as OST using ML/DL methods for patients with GBM
is vital to improve the diagnosis process and patients’ health. Below are some research ideas that
could be implemented in prospective studied to improve the performance of the OST prediction
system developed in this dissertation.
For future work, we suggest two different research directions. The first direction is based
on involving medical and biological evaluations and tests in validating our prediction system as a
reliable computer aided diagnosis method. The second direction focuses on proposing the possible
ideas to improve the function and the performance of our OST prediction system.
A. Evaluations from the perspective of the biology and medical decisions
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We designed and developed the OST prediction system to enhance the patients’ health, to
increase the precision of the diagnosis process, and to accelerate the GBM brain tumor diagnosis.
For future work, we suggest that physiology and biology evaluations be involved to study the
effectiveness of our developed OST classification system on improving the diagnosis and
treatment processes. We suggest the following procedure to evaluate our prediction system from
the physiology and biology perspectives:
1. Prepare a group of patients that are diagnosed recently with GBM tumors.
2. Collect the four mpMRI modalities (T1, T1 Gd, T2, and FLAIR) for each patient. Then
collect patients' age, survival time, and age information.
3. Enter the collected data of each patient to our OST classification system to produce the
estimated OST.
4. Compare our system estimations with experts’ predictions and the actual OST after
patients’ death. Also studying the variations of treatment plans based on the predicted
OST from our prediction system compared with the medical decisions.

B. Improving the performance and functionality of our OST system
1.

Although the survival BraTS 2020 data is considered as one of the best labeled survival data,
the size of the training dataset is still a critical challenge to develop an accurate classification
system. Especially, the performance of ML prediction models can be improved if the size of
the dataset is increased. Moreover, increasing the size of the radiomic features vector is
correlated with the size of the dataset. Therefore, collecting more survival data based on
mpMRI scans with clinical data will not only improve the performance of the prediction
system, but it will also allow us to investigate the effect of increasing the size of features
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vector that contains various types of radiomic features. Moreover, availability of big survival
data will allow to investigate the power of DL in developing numerous robust features in the
training process without need to be identified by researchers in the preprocessing step.
2.

Study and test information-fusion strategy based on features-fusion level for all the methods
that were proposed and developed in this dissertation (presented in Chapter three). In
addition, the performance of the OST prediction system could be improved when more
clinical information is involved, such as patient gender, type of the tumor (primary,
secondary), and availability of the resection status for all samples of the data.

3.

Improving the performance of the DL segmentation model increases the value of the radiomic
features based on size, shape, and location information. We believe that developing more
complex segmentation model will improve the segmentation results. The suggested
modifications on our DL segmentation model to improve prediction results include: increase
the three encoder/decoder stages to four stages, use other nonlinear activation functions
instead of ReLU, use multi loss functions instead of GDL, increase the size of the training
batch to 128 × 128 × 128 × 4, and ensemble DL segmentation models.

4.

Using multimodal data is essential to improve the data bias problem. With multimodal data,
new information can be utilized to develop an accurate prediction system. Therefore, adding
genomic information in the training process could improve the classification accuracy of the
OST prediction system. In fact, involving genomic information in developing the OST for
patients with GBM tumors was one of our proposed idea in this dissertation. However, we did
not get enough genomic information for all samples in the BraTS data to test and evaluate this
idea.
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5.

Expand the number of performing tasks to include the following classification tasks: multilevel brain tumor classifications, benign and malignant tumors classifications, different types
of tumors classifications. To implement all these tasks, multi-modal data, and large data are
essential to develop an integrated automatic prediction system.
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Appendix A- Characteristics of the BraTS Dataset

Table A.1 Source of radiographic data for patients (n) provided in TCIA [31].
Collection

n

Institutions contributed data –(n)

TCGA

Scanner (strength

ID

in T)

Henry Ford Hospital, Detroit, MI— (74)

TCGA-06

CWRU School of Medicine, Cleveland, OH— (38)

TCGA-19

University of California, San Francisco, CA— (32)

TCGA-08

Emory University, Atlanta, GA— (31)

TCGA-14

MD Anderson Cancer Center, Houston, TX— (25)

TCGA-02

Duke University School of Medicine, Durham, NC— (24)

TCGA-12

GE (1.5, 3): Genesis Signa,
Signa Excite
Siemens (1.5, 3): Avanto,
Symphony, Verio
GE (1.5, 3): Genesis Signa,
Signa Excite
Philips (1.5): InteraSiemens
(1.5, 3): Avanto, Trio

TCGA-GBM

262

GE: Genesis Signa, Signa
Excite
GE (1.5): Genesis Signa,
Signa HDx, Signa Excite
Siemens (1.5, 3): Avanto,
Trio, Symphony

Thomas Jefferson University, Philadelphia, PA— (22)

TCGA-76

Philips (1.5, 3): Achieva
Siemens (1.5): Magnetom
Vision

Fondazione IRCCS Instituto Neuroligico C. Besta, Milan,

TCGA-27

Italy— (16)

Philips (0.5): Intera Siemens
(1.5): Avanto

St Joseph Hospital/Medical Center, Phoenix, AZ— (98)

TCGA-HT

GE (1.5, 3): Signa Excite,
Signa HDx, Signa HDxt

Henry Ford Hospital, Detroit, MI— (57)

TCGA-DU

Hitachi (1.16): Oasis
GE (1.5, 3): Genesis, Signa
Excite, Signa HDxt,
Philips (1.5, 3): Intera,
Ingenia

Case Western Reserve University, Cleveland, OH— (22)

TCGA-FG

Thomas Jefferson University, Philadelphia, PA— (20)

TCGA-CS

Siemens (1.5, 3): Avanto,
Symphony, Skyra, Verio

TCGA-LGG

199

GE (1.5): Genesis Signa,
Signa HDxt
Philips (1.5, 3): Achieva
Siemens (1.5): Magnetom
Vision

University of North Carolina, Chapel Hill, NC— (2)
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TCGA-EZ

Siemens (3): TrioTim

Table A.2 Summarize the original characteristics of the BraTS mpMRI modalities [242].
Acronym

MRI Sequence

Property

Acquisition

Slice
Thickness

T1

T1 Gd

T1-weighted

T1-weighted

Native image

Sagittal or

Variable (1-

Axial

5mm)

Post-contrast

Axial 3D

Variable

enhancement

acquisition

(Gadolinium)

T2

T2-weighted

Native image

Axial 2D

Variable (2-4
mm)

T2-FLAIR

T2-weighted

Native image

Axial or
Coronal or
Sagittal 2D
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Variable

Table A.3 Distribution of BraTS challenges (2012-2021) datasets across train, validation
and test phases [107].
Year

Total

Training

Validation Testing

Tasks

Timepoint

Data

Data

Data

Data

2012

50

35

NA

15

Segmentation

Preoperative

2013

60

35

NA

25

Segmentation

Preoperative

2014

238

200

NA

38

Segmentation

Preoperative

2015

253

200

NA

53

Segmentation

Longitudinal

Disease
progression
2016

391

200

NA

191

Segmentation

Longitudinal

Disease
progression
2017

477

285

46

146

Segmentation

Preoperative

Survival
prediction
2018

542

285

66

191

Segmentation

Preoperative

Survival
prediction
2019

626

335

125

166

Segmentation

Preoperative

Survival
prediction
2020

660

369

125

166

Segmentation

Preoperative

Survival
prediction
2021

2040

1251

219

570

Segmentation
MGMT
classification

179

Preoperative

Appendix B- Histogram Distribution for BraTS MRI Scans

B.1 Histogram Distribution for MRI images in BraTS 2017 Data
The OTSU thresholding method was used to extract the region of interest (ROI), the brain
region, in the MRI images using Matlab to eliminate the effect of black pixels in the background
of the MRI images. Then histogram distribution was calculated for the extracted ROI. The
histogram distributions for all FLAIR samples in the BraTS 2017 training dataset are as displayed
below. Where the number above each distribution indicates the number of the sample in the BraTS
2017 training dataset.
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